[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 174
1. Connolly G, Wladis E, Masselam K, Weinberg DA: Contralateral orbital melanoma 28 years following enucleation for choroidal melanoma. Orbit; 2007 Dec;26(4):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He underwent radiotherapy of the residual tumor at the left orbital apex, as well as radiotherapy of small liver and lung nodules felt to likely represent metastatic melanoma.
  • Five years later, he was still alive and well, with no further tumor demonstrable in the orbit, lung or liver.
  • We discuss some hypotheses that may explain such tumor behavior.
  • While melanoma is often considered a highly malignant and lethal tumor, some melanomas are characterized by a more benign course.
  • [MeSH-major] Choroid Neoplasms / pathology. Melanoma / secondary. Orbital Neoplasms / secondary
  • [MeSH-minor] Aged. Exophthalmos. Eye Enucleation. Humans. Male. Tomography, X-Ray Computed. Visual Acuity

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18097971.001).
  • [ISSN] 0167-6830
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. de Silva DJ, Tay E, Rose GE: Schwannomas of the lacrimal gland fossa. Orbit; 2009;28(6):433-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Schwannomas are rare benign nerve sheath tumours that account for 1% of orbital tumours and, although sometimes associated with neurofibromatosis, most occur as isolated lesions and arise from branches of the ciliary or trigeminal nerves.
  • On a presumptive preoperative diagnosis of pleomorphic adenoma, the patient underwent a bone-swinging lateral orbitotomy with intact excision of a moderately-firm, lobulated lesion which proved to be a Schwannoma.
  • [MeSH-major] Eye Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology. Neurilemmoma / pathology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Female. Glial Fibrillary Acidic Protein / analysis. Humans. S100 Proteins / analysis. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19929679.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Glial Fibrillary Acidic Protein; 0 / S100 Proteins
  •  go-up   go-down


3. Krause E, Gürkov R, Klauss V: [Solitary fibrous tumor in the orbit. Case report and review of the literature]. HNO; 2009 Feb;57(2):169-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Solitary fibrous tumor in the orbit. Case report and review of the literature].
  • [Transliterated title] Solitärer fibröser Tumor in der Orbita. Fallbericht und Literaturübersicht.
  • BACKGROUND: Solitary fibrous tumor (SFT) is a mesenchymal neoplasm with a benign growth behavior.
  • Tumor growth over 7 years led to a severe exophthalmos with loss of vision.
  • CONCLUSION: SFT is a rare differential diagnosis of orbital lesions and can be appropriately treated by surgical resection.
  • [MeSH-major] Blindness / etiology. Blindness / prevention & control. Orbital Neoplasms / complications. Orbital Neoplasms / surgery. Solitary Fibrous Tumors / complications. Solitary Fibrous Tumors / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eye (Lond). 2001 Feb;15(Pt 1):102-4 [11318269.001]
  • [Cites] Neuropathology. 2006 Dec;26(6):557-63 [17203593.001]
  • [Cites] Int J Oral Maxillofac Surg. 2005 May;34(3):331-3 [15741045.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1241-5 [11846919.001]
  • [Cites] HNO. 2006 Dec;54(12):962-6 [16477466.001]
  • [Cites] HNO. 2007 Apr;55(4):287-92 [16622693.001]
  • [Cites] Am J Surg Pathol. 1998 Dec;22(12 ):1501-11 [9850176.001]
  • [Cites] J Thorac Cardiovasc Surg. 1978 Mar;75(3):363-72 [633933.001]
  • [Cites] Histopathology. 2006 Jan;48(1):3-12 [16359532.001]
  • [Cites] Eye (Lond). 1996;10 ( Pt 3):396-9 [8796170.001]
  • [Cites] Orbit. 2006 Mar;25(1):45-50 [16527776.001]
  • [Cites] Cancer. 2002 Feb 15;94(4):1057-68 [11920476.001]
  • [Cites] Korean J Radiol. 2005 Jul-Sep;6(3):136-42 [16145288.001]
  • [Cites] Can J Ophthalmol. 1997 Dec;32(7):432-5 [9435973.001]
  • [Cites] Virchows Arch. 1997 Jun;430(6):445-53 [9230909.001]
  • [Cites] Am J Surg Pathol. 2001 Nov;25(11):1424-8 [11684960.001]
  • [Cites] Surv Ophthalmol. 2003 Sep-Oct;48(5):544-54 [14499820.001]
  • (PMID = 19221826.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 18
  •  go-up   go-down


Advertisement
4. Sidani CA, Karam AR, Bruce JH, Sklar E: Osteoblastoma of the frontal sinuses presenting with headache and blurred vision: case report and review of the literature. J Radiol Case Rep; 2010;4(6):1-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoblastoma is a rare benign bone tumor that usually arises in the vertebral column and long bones of young adults.
  • We report an osteoblastoma of both frontal sinuses in a 23-year-old male who presented with headache and blurry vision in the left eye.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22470734.001).
  • [ISSN] 1943-0922
  • [Journal-full-title] Journal of radiology case reports
  • [ISO-abbreviation] J Radiol Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3303412
  • [Keywords] NOTNLM ; Frontal sinus / exophthalmos / osteoblastoma
  •  go-up   go-down


5. Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT: Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Am J Ophthalmol; 2005 Aug;140(2):193-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DESIGN: Interventional non-randomized clinical study.
  • Two were imaged before treatment of their primary tumor.
  • The mean time from initial diagnosis to metastasis was 47 months (range 0 to 154).
  • PET/computed tomography imaging also detected benign lesions of the bone and lymph nodes in three patients (15%).
  • [MeSH-major] Choroid Neoplasms / pathology. Choroid Neoplasms / radionuclide imaging. Melanoma / radionuclide imaging. Melanoma / secondary. Positron-Emission Tomography / methods. Whole-Body Counting / methods
  • [MeSH-minor] Aged. Aged, 80 and over. Bone Neoplasms / radionuclide imaging. Bone Neoplasms / secondary. Female. Fluorodeoxyglucose F18. Humans. Liver Neoplasms / radionuclide imaging. Liver Neoplasms / secondary. Lung Neoplasms / radionuclide imaging. Lung Neoplasms / secondary. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Radiopharmaceuticals. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15992753.001).
  • [ISSN] 0002-9394
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


6. Yao J, Chen RJ, Sun XH: [Analysis of the relationship between pathology and recurrence of primary lacrimal epithelial tumors]. Zhonghua Yan Ke Za Zhi; 2006 Jul;42(7):590-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: 128 cases of primary lacrimal epithelial tumors including benign mixed tumor (74 cases, 57.8%), adenoid cystic carcinoma (22 cases, 17.2%) and malignant mixed tumor (18 cases, 14.1%) were subjected in the study.
  • RESULTS: The recurrent rate of benign mixed tumor, adenoid cystic carcinoma and malignant mixed tumor was 23.0%, 18.2% and 27.8%, respectively.
  • The recurrence of benign mixed tumor was statistically related to pathological classification and encapsulates.
  • The pathological features were decisive in diagnosis, selection of treatment and the time of follow-up.
  • [MeSH-major] Carcinoma, Adenoid Cystic / pathology. Eye Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology. Neoplasms, Complex and Mixed / pathology
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17081415.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


7. Sojka P, Pogrzebielski A, Orłowska-Heitzman J, Romanowska-Dixon B: [Mesectodermal leiomyoma of the ciliary body--case report]. Klin Oczna; 2009;111(10-12):350-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: In the left eye of the 15 years old female patient presenting 2 months history of deterioration of visual acuity a medium-pigmented, dome-shaped tumor at the inferotemporal side was detected.
  • Due to the size of the tumor and the impossibility of conducting conservative treatment the globe was eventually enucleated.
  • RESULTS: The final diagnosis was established on the basis of histopathological microscopic examination and immunohistochemical stains.
  • CONCLUSIONS: Mesectodermal leiomyoma of the ciliary body is an extremely rare benign tumor, which originates from neural crests.
  • [MeSH-major] Ciliary Body / pathology. Leiomyoma / diagnosis. Uveal Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Eye Enucleation. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20169895.001).
  • [ISSN] 0023-2157
  • [Journal-full-title] Klinika oczna
  • [ISO-abbreviation] Klin Oczna
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


8. Shields JA, Eagle RC Jr, Shields CL, Brown GC, Lally SE: Malignant transformation of congenital hypertrophy of the retinal pigment epithelium. Ophthalmology; 2009 Nov;116(11):2213-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A 56-year-old black woman was referred for an asymptomatic fundus lesion in her left eye.
  • It had features typical of CHRPE, but there was a small elevated nodule within the flat component, and the diagnosis was adenoma of the retinal pigment epithelium (RPE) arising from CHRPE.
  • Thirteen years after the initial diagnosis, the patient returned with severe visual loss and no view of the fundus resulting from cataract and posterior synechia.
  • Ultrasonography revealed a total retinal detachment and a pedunculated tumor measuring 7.5 mm in thickness.
  • The eye was enucleated and studied histopathologically.
  • MAIN OUTCOME MEASURES: Clinical evaluation and correlation of clinical findings with histopathologic results of the enucleated eye.
  • RESULTS: Histopathologically, the mass was composed of a proliferation of atypical RPE cells with a marked infiltration of benign plasma cells.
  • Typical features of CHRPE were present at the base of the tumor.
  • The final diagnosis was adenocarcinoma arising from CHRPE.
  • CONCLUSIONS: Congenital hypertrophy of the retinal pigment epithelium, once considered to be a benign and stationary lesion, may spawn a malignant neoplasm.
  • [MeSH-major] Adenocarcinoma / pathology. Cell Transformation, Neoplastic / pathology. Retinal Neoplasms / pathology. Retinal Pigment Epithelium / pathology
  • [MeSH-minor] Eye Enucleation. Female. Humans. Hypertrophy / congenital. Middle Aged. Retinal Detachment / pathology. Retinal Detachment / ultrasonography

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19744732.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


9. Charles NC, Lisman RD, Lelli GJ Jr: Subperiosteal orbital fibroma. Ophthalmic Surg Lasers Imaging; 2008 Nov-Dec;39(6):517-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathologic examination showed a benign fibroma, a lesion that to the authors' knowledge has never been previously reported in this location.
  • [MeSH-major] Fibroma / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Aged. Biomarkers, Tumor / analysis. Female. Humans. Neoplasm Proteins / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19065988.001).
  • [ISSN] 1542-8877
  • [Journal-full-title] Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye
  • [ISO-abbreviation] Ophthalmic Surg Lasers Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


10. Demirci H, Shields CL, Eagle RC Jr, Shields JA: Giant cell angiofibroma, a variant of solitary fibrous tumor, of the orbit in a 16-year-old girl. Ophthal Plast Reconstr Surg; 2009 Sep-Oct;25(5):402-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell angiofibroma, a variant of solitary fibrous tumor, of the orbit in a 16-year-old girl.
  • A 16-year-old girl presented with diplopia and gradual-onset, painless proptosis of the left eye.
  • Five years later, her symptoms recurred, and she was referred to the Oncology Service, Wills Eye Institute.
  • Histopathologic examination showed benign, patternless spindle-cell proliferation with prominent intrinsic vascularity and multinucleated giant cells, consistent with giant cell angiofibroma, a variant of solitary fibrous tumor.
  • Giant cell angiofibroma, a variant of solitary fibrous tumor, is a rare orbital tumor that presents as a well-circumscribed, enhancing mass and can be found in children.
  • [MeSH-major] Angiofibroma / pathology. Giant Cell Tumors / pathology. Orbital Neoplasms / pathology. Solitary Fibrous Tumors / pathology
  • [MeSH-minor] Adolescent. Antigens, CD34 / metabolism. Biomarkers, Tumor / metabolism. Diplopia / diagnosis. Exophthalmos / diagnosis. Female. Humans. Magnetic Resonance Imaging. Ophthalmologic Surgical Procedures

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19966660.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Biomarkers, Tumor
  •  go-up   go-down


11. Perez DE, Pires FR, Almeida OP, Kowalski LP: Epithelial lacrimal gland tumors: a clinicopathological study of 18 cases. Otolaryngol Head Neck Surg; 2006 Feb;134(2):321-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: Epithelial lacrimal gland tumors are mainly PA and ACC, and malignancies are more common than benign tumors.
  • Although ACC presented typically with advanced clinical stage, 33% of the patients survived without tumor recurrence or metastasis.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Adenoid Cystic / pathology. Eye Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16455384.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


12. Wali UK, Al-Mujaini A: Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol; 2010 Sep;3(3):117-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It represents 1-5.5% of eyelid malignancies and is considered to be the third most common eyelid malignancy after basal cell and squamous cell carcinomas, although few reports placed this tumor as second most common after basal cell carcinoma.
  • A delay in diagnosis, which can be attributed primarily to ability of this tumor to masquerade as more benign conditions, often leads to inappropriate management with increased morbidity and mortality rates.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21120046.001).
  • [ISSN] 0974-7842
  • [Journal-full-title] Oman journal of ophthalmology
  • [ISO-abbreviation] Oman J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2992157
  • [Keywords] NOTNLM ; Moh’s / nodular / pagetoid / sebaceous gland carcinoma
  •  go-up   go-down


13. Currie ZI, Rose GE: Long-term risk of recurrence after intact excision of pleomorphic adenomas of the lacrimal gland. Arch Ophthalmol; 2007 Dec;125(12):1643-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Medical records were reviewed for 133 patients and only those patients with 5 years or more of follow up were classified into the following 5 subgroups: those with intact excision (group IA, n = 46), those with surgically intact excision but areas of complete attenuation of the pseudocapsule at histologic analysis (group IB, n = 7), those with previous inadvertent incisional biopsy (group IIA, n = 9), those with breach of the pseudocapsule during attempted intact excision (group IIB, n = 5), and those undergoing definitive surgery because of tumor recurrence after previous incomplete excision (group III, n = 5).
  • RESULTS: Seventy-two patients were followed up longer than 5 years; there were no known tumor recurrences among 61 patients excluded with shorter follow-up.
  • Patients in groups IA and IB exhibited no tumor recurrences at 8.2 to 34.1 years of follow-up.
  • A benign recurrence occurred along the superior orbital fissure in 1 patient in group IIA 12(1/2) years after the initial surgery and was resected.
  • Long-term follow-up is, however, necessary when there has been tumor disruption, either inadvertently during previous biopsy or by capsular breach during definitive excision.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Lacrimal Apparatus Diseases / pathology. Neoplasm Recurrence, Local / diagnosis
  • [MeSH-minor] Adult. Aged. Eye Neoplasms. Female. Follow-Up Studies. Humans. Male. Middle Aged. Ophthalmologic Surgical Procedures. Risk Factors. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18071115.001).
  • [ISSN] 0003-9950
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Singh R, Chattopadhyay A, Agarwal A, Bhattacharya SK, Bhattacharya AK: Oxidants and ocular tumors. Ann Ophthalmol (Skokie); 2006;38(3):231-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oxidants and ocular tumors.
  • Serum superoxide dismutase and catalase assays were performed using spectrophotometry in 60 adults and children with benign or malignant tumors and in controls.
  • These enzymes may be of value in the early diagnosis of malignant intraocular tumor, especially retinoblastoma.
  • [MeSH-major] Eye Neoplasms / etiology. Oxidants / metabolism. Retinoblastoma / etiology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17416959.001).
  • [ISSN] 1558-9951
  • [Journal-full-title] Annals of ophthalmology (Skokie, Ill.)
  • [ISO-abbreviation] Ann Ophthalmol (Skokie)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oxidants; EC 1.11.1.6 / Catalase; EC 1.15.1.1 / Superoxide Dismutase
  •  go-up   go-down


15. Cohen AB, Lessell S: Angiogenesis and pituitary tumors. Semin Ophthalmol; 2009 May-Jun;24(3):185-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They are typically slow-growing and histologically benign tumors, but can become clinically destructive, invade adjacent structures, and recur after treatment.
  • Unlike many other tumors that become aggressive and appear to depend upon angiogenesis in the process, pituitary adenomas tend to do so through non-angiogenic means.
  • [MeSH-major] Neovascularization, Pathologic. Pituitary Neoplasms / blood supply
  • [MeSH-minor] Adenoma / blood supply. Adenoma / metabolism. Adenoma / pathology. Animals. Biomarkers, Tumor / biosynthesis. Blood Vessels / pathology. Humans. Neoplasm Invasiveness. Vascular Endothelial Growth Factor A / biosynthesis

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19437356.001).
  • [ISSN] 1744-5205
  • [Journal-full-title] Seminars in ophthalmology
  • [ISO-abbreviation] Semin Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Vascular Endothelial Growth Factor A
  • [Number-of-references] 22
  •  go-up   go-down


16. Yan XM, Chen Y, Li HL, Rong B, Yang SL: [Retrospective analysis of ocular cicatricial pemphigoid]. Zhonghua Yan Ke Za Zhi; 2010 Sep;46(9):781-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Retrospective analysis of ocular cicatricial pemphigoid].
  • OBJECTIVE: To analyze the clinical characterization of ocular cicatricial pemphigoid (OCP).
  • It was two to five years from the first time to see a doctor to definite diagnosis.
  • All of cases have been prescribed antibiotic eye drops for a long times, one case has been undergone three times trichiasis operation and made the disease progression.
  • Only in 1 case, there was slight increase of iron protein as tumor mark.
  • [MeSH-major] Diagnostic Errors. Pemphigoid, Benign Mucous Membrane


17. Orawiec B, Grałek M, Stefańczyk L, Niwald A: Applicability of ultrasound in ocular tumors in children and adolescents. Klin Oczna; 2005;107(7-9):437-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Applicability of ultrasound in ocular tumors in children and adolescents.
  • PURPOSE: Evaluation of the applicability of ultrasound in children diagnosed for neoplasm of the eye.
  • Evaluation of Doppler ultrasound in visualizing blood vessels within the lesion in eye ball, eye socket and eye lids.
  • Establishing the value of the obtained data concerning the image of vessels and blood flow for the diagnosis, monitoring the course of disease and results of treatment.
  • MATERIAL AND METHODS: The study comprised 80 patients diagnosed and treated for neoplasm of the eye.
  • The presence of vessels in tumor mass and blood flow in tumors were useful for differentiation between malignant and benign tumors.
  • The obtained pictures of vessels and flow character are typical for some tumors, which together with histopathology of tumors enables establishing of correct diagnosis.
  • [MeSH-major] Eye Neoplasms / ultrasonography

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16416991.001).
  • [ISSN] 0023-2157
  • [Journal-full-title] Klinika oczna
  • [ISO-abbreviation] Klin Oczna
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


18. Kim HJ, McCormick SA, Nath S, Moskowitz B, Milman T: Melanocytic nevi of the tarsal conjunctiva: clinicopathologic case series with review of literature. Ophthal Plast Reconstr Surg; 2010 Nov-Dec;26(6):438-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Clinicopathologic series of 4 cases diagnosed at the New York Eye and Ear Infirmary between January 1990 and April 2009.
  • Biopsy, therefore, is prudent as histopathology alone allows documentation of the benign nature of these lesions.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Eyelid Neoplasms / pathology. Nevus, Pigmented / pathology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Child, Preschool. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20683369.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


19. Schulze S, Hoerle S, Koop G, Barth PJ, Huegens-Penzel M, Strempel I: Intravascular papillary endothelial hyperplasia - a rare finding in the orbital region. Ophthalmologica; 2008;222(3):213-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intravascular papillary endothelial hyperplasia is a benign lesion of vascular origin.
  • We report the case of a 58-year-old woman sent to our clinic for surgery of an orbital fat prolapse at her right eye.
  • After MRI, a biopsy was carried out leading to the histological diagnosis of intravascular papillary endothelial hyperplasia.
  • The complete excision of the remaining tumor was performed 8 weeks later.
  • [MeSH-major] Endothelium, Vascular / pathology. Orbital Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Hyperplasia. Magnetic Resonance Imaging. Middle Aged. Ophthalmologic Surgical Procedures / methods

  • Genetic Alliance. consumer health - Intravascular papillary endothelial hyperplasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel
  • (PMID = 18497532.001).
  • [ISSN] 1423-0267
  • [Journal-full-title] Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
  • [ISO-abbreviation] Ophthalmologica
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


20. Madrid C, Aziza J, Hlali A, Bouferrache K, Abarca M: Melanotic neuroectodermal tumour of infancy: a case report and review of the aetiopathogenic hypotheses. Med Oral Patol Oral Cir Bucal; 2010 Sep;15(5):e739-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanotic neuroectodermal tumour of infancy: a case report and review of the aetiopathogenic hypotheses.
  • The tooth buds of 6.1 and 6.2 were closely related to the tumour and so were removed.
  • The pathology of the lesion confirmed a melanotic neuroectodermal tumour of infancy.
  • The melanotic neuroectodermal tumour of infancy (MNTI) has been described as a rare benign pigmented painless swelling that usually occurs in the anterior region of the maxilla and in the incisor region.
  • According to Krompecher this tumour derives from epithelial nests evolved at the time of embryonic fusion of the facial processes.
  • It has also been suggested that the tumour arises from the retinal anlage by a pinching-off process of neuroepithelium during the formation of embryonic eye.
  • More recently, the presence of high levels of vanillylmandelic acid suggest a neural origin of the tumour.
  • [MeSH-major] Maxillary Neoplasms. Neuroectodermal Tumor, Melanotic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173714.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  •  go-up   go-down


21. Siepmann K, Wannke B, Neumann D, Rohrbach JM: Subcutaneous tumor of the lower eyelid: a potential manifestation of a Dirofilaria repens infection. Eur J Ophthalmol; 2005 Jan-Feb;15(1):129-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subcutaneous tumor of the lower eyelid: a potential manifestation of a Dirofilaria repens infection.
  • PURPOSE: To report a case of Dirofilaria repens presenting as a subcutaneous tumor of the lower eyelid.
  • RESULTS: A 29-year-old man of Greek origin without systemic symptoms presented with a 3-week history of a small painless mass localized in the medial part of the lower eyelid.
  • CONCLUSIONS: Infection with the nematode Dirofilaria repens has to be considered in the differential diagnosis of malignant and benign tumors of subcutaneous periocular tissues in patients who traveled to endemic areas.
  • [MeSH-major] Dirofilaria / isolation & purification. Dirofilariasis / diagnosis. Eye Infections, Parasitic / diagnosis. Eyelid Diseases / diagnosis. Eyelid Neoplasms / diagnosis. Skin Diseases, Parasitic / diagnosis
  • [MeSH-minor] Adult. Animals. Diagnosis, Differential. Humans. Male

  • MedlinePlus Health Information. consumer health - Eyelid Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15751252.001).
  • [ISSN] 1120-6721
  • [Journal-full-title] European journal of ophthalmology
  • [ISO-abbreviation] Eur J Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Ayberk G, Ozveren MF, Uzum N, Tosun O, Akcay EK: Cellular schwannoma of the greater superficial petrosal nerve presenting with abducens nerve palsy and xerophthalmia: case report. Neurosurgery; 2008 Oct;63(4):E813-4; discussion E814
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schirmer's test revealed decreased tear secretion in the right eye.
  • It was thought that the schwannoma in our patient originated from the greater superficial petrosal nerve, based on the location of the tumor in addition to the absence of partial Horner's syndrome and a persistent decrease in tear secretion.
  • INTERVENTION: The tumor was exposed with the use of a right subtemporal extradural approach and removed entirely.
  • Pathological evaluation of the tumor revealed a CS.
  • No adjuvant treatment was applied because of the tumor's benign character.
  • The greater superficial petrosal nerve schwannoma should be considered in the differential diagnosis of the abducens nerve palsy and petrous apex mass.

  • Genetic Alliance. consumer health - Schwannoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981849.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G: How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol; 2010 Sep;63(3):361-74; quiz 375-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors.
  • Dermoscopy is a noninvasive tool that can be helpful in the diagnosis of nonpigmented skin tumors.
  • This is because dermoscopy permits the visualization of key vascular structures that are usually not visible to the naked eye.
  • Much work has concentrated on the identification of specific morphologic types of vessels that allow a classification into melanocytic versus nonmelanocytic and benign versus malignant nonpigmented skin tumors.
  • Aside from vascular morphology, the architectural arrangement of vessels within the tumor and the presence of additional dermoscopic clues are equally important for the diagnosis.
  • Part I discusses the dermoscopic vascular patterns of benign and malignant melanocytic skin tumors.
  • Part II discusses the dermoscopic vascular patterns of benign and malignant nonmelanocytic nonpigmented skin tumors.
  • In each part, additional special management guidelines for melanocytic and nonmelanocytic nonpigmented skin tumors, respectively, will be discussed.
  • [MeSH-major] Blood Vessels / pathology. Dermoscopy / methods. Melanocytes / pathology. Skin Neoplasms / blood supply. Skin Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Education, Medical, Continuing. Female. Humans. Male. Melanoma / blood supply. Melanoma / diagnosis. Melanoma / pathology. Melanoma, Amelanotic / blood supply. Melanoma, Amelanotic / diagnosis. Melanoma, Amelanotic / pathology. Regional Blood Flow. Skin / blood supply

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20708469.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 47
  •  go-up   go-down


24. Kernt M, Schaller UC, Stumpf C, Ulbig MW, Kampik A, Neubauer AS: Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap). Clin Ophthalmol; 2010;4:829-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Choroidal melanoma is the most prevalent primary neoplasia among malignant ocular tumors, and metastasis often occurs before the primary tumor is diagnosed.
  • We investigated the imaging properties of clinically diagnosed melanocytic choroidal tumors using a nonmydriatic ultra-wide-field scanning laser ophthalmoscope (SLO) with two laser wavelengths to distinguish benign from malignant lesions.
  • METHODS: In a consecutive series of 49 patients with clinically diagnosed melanocytic choroidal tumors in one eye, 29 had established melanoma (defined by proven growth on repeated US follow-up) and 20 had nevi (defined by no malignancy according to clinical, US, and growth characteristics for at least 2 years).
  • Measurements of the tumor base using the Optomap software were compared with US B-scan measurements.
  • RESULTS: Measurements of tumor base correlated well between SLO and US with r = 0.61 (T-direction) and r = 0.51 (L-direction).
  • CONCLUSIONS: In this first, limited series, nonmydriatic SLO imaging with two laser wavelengths permitted to differentiate malignant ocular tumors from nonmalignant lesions with high diagnostic accuracy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AMA Arch Ophthalmol. 1959 Aug;62(2):196-202 [13669796.001]
  • [Cites] Trans Am Ophthalmol Soc. 1995;93:259-75; discussion 275-9 [8719682.001]
  • [Cites] Br J Ophthalmol. 1995 Oct;79(10):892-9 [7488576.001]
  • [Cites] Ophthalmology. 1994 Apr;101(4):710-6; discussion 717 [8152767.001]
  • [Cites] Arch Ophthalmol. 1988 Mar;106(3):381-5 [3278703.001]
  • [Cites] Ophthalmic Res. 1988;20(5):298-303 [3186201.001]
  • [Cites] Ophthalmology. 1986 May;93(5):661-5 [3725325.001]
  • [Cites] Int Ophthalmol Clin. 1980 Summer;20(2):71-92 [6995393.001]
  • [Cites] Int Ophthalmol Clin. 1979 Winter;19(4):127-210 [395120.001]
  • [Cites] Cancer. 1979 Mar;43(3):883-8 [427730.001]
  • [Cites] Arch Ophthalmol. 1977 Apr;95(4):593-7 [849182.001]
  • [Cites] Am J Ophthalmol. 1977 Mar;83(3):299-323 [848534.001]
  • [Cites] Am J Ophthalmol. 1973 Jul;76(1):19-25 [4717339.001]
  • [Cites] Acta Ophthalmol (Copenh). 1975 Mar;53(2):139-52 [1173995.001]
  • [Cites] Bibl Ophthalmol. 1975;(83):141-54 [1131210.001]
  • [Cites] Cancer. 1967 Apr;20(4):493-507 [6019824.001]
  • [Cites] Arch Ophthalmol. 1966 Dec;76(6):784-96 [5924936.001]
  • [Cites] Circulation. 2010 Mar 30;121(12):1459-60 [20351304.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2823-8 [18408179.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1581-90 [16636839.001]
  • [Cites] Cancer Control. 2004 Sep-Oct;11(5):304-9 [15377989.001]
  • [Cites] Can J Ophthalmol. 2004 Jun;39(4):351-7 [15327099.001]
  • [Cites] Can J Ophthalmol. 2004 Jun;39(4):343-50 [15327098.001]
  • [Cites] Curr Opin Ophthalmol. 2002 Jun;13(3):135-41 [12011680.001]
  • [Cites] Ophthalmology. 2000 Aug;107(8):1443-9 [10919885.001]
  • [Cites] Arch Ophthalmol. 2000 Mar;118(3):360-4 [10721958.001]
  • (PMID = 20689737.001).
  • [ISSN] 1177-5483
  • [Journal-full-title] Clinical ophthalmology (Auckland, N.Z.)
  • [ISO-abbreviation] Clin Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Other-IDs] NLM/ PMC2915871
  • [Keywords] NOTNLM ; choroidal melanoma / imaging / nevus / ultra-wide-field scanning laser ophthalmoscopy
  •  go-up   go-down


25. Benoit MM, Handzel O, McKenna MJ, Deschler DG: A 42-year-old man with facial nerve weakness and multiple recurrent pleomorphic adenoma. Otol Neurotol; 2010 Sep;31(7):1157-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To describe a case and discuss the differential diagnosis of facial nerve paresis presenting years after resection of multiple recurrent parotid pleomorphic adenoma.
  • MAIN OUTCOME MEASURES: Histopathologic diagnosis and treatment outcome.
  • RESULTS: Final diagnosis of recurrent pleomorphic adenoma causing compression of the facial nerve at the stylomastoid foramen.
  • CONCLUSION: Facial nerve weakness caused by a benign salivary gland tumor is rare.
  • [MeSH-major] Adenoma, Pleomorphic / complications. Facial Paralysis / etiology. Parotid Neoplasms / complications
  • [MeSH-minor] Adult. Humans. Immunosuppressive Agents / therapeutic use. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local. Temporal Bone / pathology. Tomography, X-Ray Computed

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20657328.001).
  • [ISSN] 1537-4505
  • [Journal-full-title] Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • [ISO-abbreviation] Otol. Neurotol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  •  go-up   go-down


26. Saornil MA, Becerra E, Méndez MC, Blanco G: [Conjunctival tumors]. Arch Soc Esp Oftalmol; 2009 Jan;84(1):7-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Tumores de la conjuntiva.
  • Conjunctival tumors are one of the most frequent of the eye and adnexa.
  • They comprise a large variety of conditions, from benign lesions such as nevus or papilloma, to malignant lesions such as epidermoid carcinoma or melanoma which may threaten visual function and the life of the patient.
  • Early diagnosis is essential for preventing ocular and systemic spread and to preserve visual function.
  • In this paper we review the clinical characteristics of the most frequent conjunctival tumors, and we discuss tumor management.
  • [MeSH-major] Conjunctival Neoplasms
  • [MeSH-minor] Carcinoma / pathology. Carcinoma / surgery. Conjunctival Diseases / pathology. Conjunctival Diseases / surgery. Eye Enucleation. Eye Evisceration. Hematologic Neoplasms / pathology. Hematologic Neoplasms / surgery. Humans. Melanoma / pathology. Melanoma / surgery. Neoplasm Invasiveness. Nevus / pathology. Nevus / surgery. Papilloma / pathology. Papilloma / surgery. Precancerous Conditions / pathology. Precancerous Conditions / surgery. Sarcoma / pathology. Sarcoma / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19173134.001).
  • [ISSN] 1989-7286
  • [Journal-full-title] Archivos de la Sociedad Española de Oftalmología
  • [ISO-abbreviation] Arch Soc Esp Oftalmol
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 47
  •  go-up   go-down


27. Horowitz G, Gil Z, Kavel O, Smith D, Sela M, Abargel A, Fliss D: [Surgical treatment of maxillary tumors]. Harefuah; 2010 Nov;149(11):704-7, 749
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this article is to review the indications, diagnosis and treatment of patients with maxillary tumors operated at Tel Aviv Sourasky Medical Center during the period 1999 - 2008.
  • METHODS: A total of 174 patients underwent surgery due to neoplasms originating in the maxillary sinus: 118 patients (68%) had malignant and 54 (32%) had benign tumors.
  • RESULTS: The most common malignancy was squamous cell carcinoma (40%), and the most common benign tumor was juvenile nasopharyngeal angiofibroma (36%).
  • In 9 cases, resection was extended to include the eye socket or base of skull, due to tumor invasion.
  • [MeSH-major] Maxillary Neoplasms / surgery
  • [MeSH-minor] Angiofibroma / mortality. Angiofibroma / surgery. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / surgery. Humans. Maxilla / surgery. Melanoma / mortality. Melanoma / surgery. Nasopharyngeal Neoplasms / mortality. Nasopharyngeal Neoplasms / surgery. Retrospective Studies. Sarcoma / mortality. Sarcoma / surgery. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21250410.001).
  • [ISSN] 0017-7768
  • [Journal-full-title] Harefuah
  • [ISO-abbreviation] Harefuah
  • [Language] heb
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Israel
  • [Chemical-registry-number] Nasopharyngeal carcinoma
  •  go-up   go-down


28. Trisvetova EL: [Clinical diagnostics of papillary fibroelastoma]. Klin Med (Mosk); 2007;85(12):7-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Papillary fibroelastoma (PFE) is a benign heart tumor, the diagnosis of which is difficult.
  • Clinical manifestations of PFE are non-specific and scarce, and for this reason the tumor is often revealed during a heart surgery of an autopsy.
  • The histogenesis of the tumor is unclear; there are several theories of PFE origin (hemodynamic effects on the myocardium, viral theory, iatrogenic theory etc.
  • ) Macroscopically the tumor is small size, villous, whitish-grey, consists of a pedicle and villi of gely-like soft or dense-elastic consistence.
  • The mobility of the tumor and the fragmentation of its tissue lead to its main complications such as obstruction of cardiac cameras (in-flow and out-flow disorders) and embolic syndrome in various basins (the brain, coronary arteries, the eye, the kidneys, and the lungs).
  • The diagnosis of PFE is made using EchoCG, preferably transesophageal one.
  • Treatment of PFE is surgical and consists of tumor or cusp removal.
  • PFE should be differentiated from other benign and malignant heart tumors, infective endocarditis, heart echinococcosis, coronary artery disease, and cerebrovascular diseases.
  • [MeSH-major] Cardiac Surgical Procedures / methods. Fibroma. Heart Neoplasms. Ventricular Function / physiology
  • [MeSH-minor] Diagnosis, Differential. Echocardiography, Transesophageal. Humans. Papillary Muscles / pathology. Papillary Muscles / ultrasonography. Prognosis

  • MedlinePlus Health Information. consumer health - Heart Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18318158.001).
  • [ISSN] 0023-2149
  • [Journal-full-title] Klinicheskaia meditsina
  • [ISO-abbreviation] Klin Med (Mosk)
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Russia (Federation)
  • [Number-of-references] 49
  •  go-up   go-down


29. Wilkins-Port CE, Ye Q, Mazurkiewicz JE, Higgins PJ: TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. Cancer Res; 2009 May 1;69(9):4081-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The phenotypic switching called epithelial-to-mesenchymal transition is frequently associated with epithelial tumor cell progression from a comparatively benign to an aggressive, invasive malignancy.
  • TGF-beta in the tumor microenvironment promotes invasive traits largely through reprogramming gene expression, which paradoxically supports matrix-disruptive as well as stabilizing processes. ras-transformed HaCaT II-4 keratinocytes undergo phenotypic changes typical of epithelial-to-mesenchymal transition, acquire a collagenolytic phenotype, and effectively invade collagen type 1 gels as a consequence of TGF-beta1 + EGF stimulation in a three-dimensional physiologically relevant model system that monitors collagen remodeling.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Sci. 2000 Jan;113 Pt 2:227-35 [10633074.001]
  • [Cites] J Surg Res. 2008 May 1;146(1):32-42 [17543340.001]
  • [Cites] J Interferon Cytokine Res. 2001 Jan;21(1):11-9 [11177576.001]
  • [Cites] Jpn J Cancer Res. 2001 Mar;92(3):257-68 [11267935.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6686-91 [11390996.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20 [11448356.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):117-29 [11586292.001]
  • [Cites] Biochemistry (Mosc). 2002 Jan;67(1):92-8 [11841344.001]
  • [Cites] Nat Rev Cancer. 2002 Jun;2(6):442-54 [12189386.001]
  • [Cites] Cancer Detect Prev. 2002;26(3):222-8 [12269770.001]
  • [Cites] J Biol Chem. 2002 Nov 22;277(47):45154-61 [12192005.001]
  • [Cites] Lab Invest. 2003 Mar;83(3):435-48 [12649344.001]
  • [Cites] Mol Cell Biochem. 2003 Nov;253(1-2):269-85 [14619979.001]
  • [Cites] Curr Opin Cell Biol. 2003 Dec;15(6):740-6 [14644200.001]
  • [Cites] J Biol Chem. 2004 May 21;279(21):22595-604 [15001579.001]
  • [Cites] Exp Eye Res. 2004 Aug;79(2):263-74 [15325573.001]
  • [Cites] Oncogene. 2008 Apr 17;27(18):2626-34 [17982486.001]
  • [Cites] Clin Exp Metastasis. 2008;25(6):593-600 [18286378.001]
  • [Cites] Oncogene. 2008 Aug 14;27(35):4841-53 [18427549.001]
  • [Cites] Ann Oncol. 2008 Sep;19(9):1566-72 [18503039.001]
  • [Cites] J Immunol. 2004 Sep 15;173(6):3605-11 [15356104.001]
  • [Cites] Curr Opin Cell Biol. 2004 Oct;16(5):558-64 [15363807.001]
  • [Cites] Ann N Y Acad Sci. 1990;580:225-32 [2186691.001]
  • [Cites] Exp Cell Res. 1991 Mar;193(1):93-100 [1995305.001]
  • [Cites] Matrix Suppl. 1992;1:368-74 [1480062.001]
  • [Cites] J Biol Chem. 1993 Aug 15;268(23):17341-7 [8349617.001]
  • [Cites] Cancer Res. 1994 Sep 1;54(17):4671-5 [8062262.001]
  • [Cites] Mol Carcinog. 1994 Sep;11(1):19-28 [7916986.001]
  • [Cites] EMBO J. 1995 Jul 3;14(13):2969-77 [7621813.001]
  • [Cites] Cell. 1996 Aug 23;86(4):531-42 [8752208.001]
  • [Cites] Biochem J. 1996 Dec 1;320 ( Pt 2):659-64 [8973581.001]
  • [Cites] Cell Growth Differ. 1997 Feb;8(2):243-50 [9040946.001]
  • [Cites] Br J Cancer. 1998 Mar;77(5):724-30 [9514050.001]
  • [Cites] Nat Med. 1998 Aug;4(8):923-8 [9701244.001]
  • [Cites] Mol Carcinog. 1998 Nov;23(3):144-58 [9833775.001]
  • [Cites] Biochem J. 1999 Apr 1;339 ( Pt 1):167-75 [10085241.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5242-54 [15371548.001]
  • [Cites] Neoplasia. 2005 Jan;7(1):57-66 [15720817.001]
  • [Cites] Br J Cancer. 2005 Jun 20;92(12):2171-80 [15928670.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Jul;3(7):493-503 [15967008.001]
  • [Cites] J Clin Invest. 2005 Jul;115(7):1714-23 [15937546.001]
  • [Cites] J Cell Biochem. 2005 Aug 1;95(5):918-31 [15861394.001]
  • [Cites] Exp Cell Res. 2006 Apr 15;312(7):1093-105 [16457817.001]
  • [Cites] Front Biosci. 2006;11:3100-20 [16720379.001]
  • [Cites] Arthritis Rheum. 2006 Oct;54(10):3244-53 [17009259.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2107-14 [17119035.001]
  • [Cites] Exp Cell Res. 2007 Jul 1;313(11):2367-77 [17467690.001]
  • [Cites] Eur Urol. 2007 Sep;52(3):791-7 [17207914.001]
  • [Cites] Oncogene. 2008 Jan 24;27(5):614-28 [17637750.001]
  • [Cites] Biochem Pharmacol. 2000 Oct 15;60(8):1091-9 [11007946.001]
  • (PMID = 19383899.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / T32-HL07194; United States / NIGMS NIH HHS / GM / GM57242; United States / NIGMS NIH HHS / GM / GM057242-11; United States / NHLBI NIH HHS / HL / T32 HL007194; United States / NIGMS NIH HHS / GM / R01 GM057242; United States / NIGMS NIH HHS / GM / R01 GM057242-11
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Collagen Type I; 0 / Plasminogen Activator Inhibitor 1; 0 / SERPINE1 protein, human; 0 / Transforming Growth Factor beta1; 62229-50-9 / Epidermal Growth Factor; EC 3.4.21.7 / Fibrinolysin; EC 3.4.24.22 / Matrix Metalloproteinase 10; EC 3.4.24.7 / Matrix Metalloproteinase 1
  • [Other-IDs] NLM/ NIHMS242077; NLM/ PMC2962982
  •  go-up   go-down


30. Berman EL, Shields CL, Sagoo MS, Eagle RC Jr, Shields JA: Multifocal blue nevus of the conjunctiva. Surv Ophthalmol; 2008 Jan-Feb;53(1):41-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Blue nevus is a congenital benign melanocytic tumor that classically occurs in the skin and carries low potential for malignant transformation.
  • A 55-year-old Hispanic woman was found to have multiple darkly pigmented lesions on her left eye.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Nevus, Blue / pathology
  • [MeSH-minor] Biopsy. Cryosurgery / methods. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Melanoma / diagnosis. Middle Aged

  • Genetic Alliance. consumer health - Nevus.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18191656.001).
  • [ISSN] 0039-6257
  • [Journal-full-title] Survey of ophthalmology
  • [ISO-abbreviation] Surv Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


31. Mineva I, Gartner W, Hauser P, Kainz A, Löffler M, Wolf G, Oberbauer R, Weissel M, Wagner L: Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing. Cell Stress Chaperones; 2005;10(3):171-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing.
  • In this study, we investigated the molecular mechanisms that affect the expression of alphaB-crystallin in benign goiters (n = 7) and highly malignant anaplastic thyroid carcinomas (ATCs) (n = 3).
  • In contrast, considerable expression of Hsp27-1 in benign and malignant thyroid tissue was demonstrated.
  • Immunofluorescence analysis revealed no relevant topological differences between benign and malignant thyrocytes in the cytoplasmic staining of both proteins.
  • In conclusion, we demonstrate downregulation of alphaB-crystallin expression in highly dedifferentiated ATCs because of a tumor-specific transcription factor pattern.
  • [MeSH-major] Carcinoma / genetics. Gene Expression Regulation, Neoplastic. Intermediate Filament Proteins / genetics. Nerve Tissue Proteins / genetics. Protein Kinases / genetics. Repressor Proteins / genetics. Thyroid Neoplasms / genetics. Transcription Factors / genetics
  • [MeSH-minor] Animals. COS Cells. Cell Line, Tumor. Cloning, Molecular. DNA, Complementary / biosynthesis. Down-Regulation. Gene Silencing. Genes, Reporter. Goiter. HSP27 Heat-Shock Proteins. Heat-Shock Proteins / analysis. Heat-Shock Proteins / metabolism. Humans. Luciferases / genetics. Neoplasm Proteins / analysis. Neoplasm Proteins / metabolism. Oligonucleotide Array Sequence Analysis. Promoter Regions, Genetic. RNA, Messenger / metabolism. Tissue Extracts / chemistry. Tissue Extracts / genetics. Tissue Extracts / metabolism. Transfection. alpha-Crystallin B Chain

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):404-13 [15706087.001]
  • [Cites] J Physiol. 2005 May 1;564(Pt 3):715-22 [15718262.001]
  • [Cites] EMBO J. 1996 Jun 3;15(11):2695-706 [8654367.001]
  • [Cites] Eur J Biochem. 1996 Nov 15;242(1):56-66 [8954153.001]
  • [Cites] J Biol Chem. 2000 Jan 28;275(4):2852-8 [10644752.001]
  • [Cites] Nature. 2000 Aug 17;406(6797):747-52 [10963602.001]
  • [Cites] Nucleic Acids Res. 2001 Jan 1;29(1):152-5 [11125075.001]
  • [Cites] J Biol Chem. 2001 May 11;276(19):16059-63 [11274139.001]
  • [Cites] J Biol Chem. 2001 Feb 2;276(5):3324-32 [11073954.001]
  • [Cites] Biochim Biophys Acta. 2001 Jul 30;1520(1):1-6 [11470154.001]
  • [Cites] Biochem Biophys Res Commun. 2001 Aug 24;286(3):433-42 [11511077.001]
  • [Cites] J Biol Chem. 2002 Oct 11;277(41):38731-6 [12140279.001]
  • [Cites] Exp Eye Res. 2003 Feb;76(2):145-53 [12565801.001]
  • [Cites] Circ Res. 2003 Feb 7;92(2):130-2 [12574138.001]
  • [Cites] Thyroid. 2003 Mar;13(3):283-90 [12729478.001]
  • [Cites] Cell Stress Chaperones. 2003 Spring;8(1):53-61 [12820654.001]
  • [Cites] Head Neck. 2003 Aug;25(8):662-70 [12884350.001]
  • [Cites] Surg Oncol. 2003 Aug;12(2):69-90 [12946479.001]
  • [Cites] Cell Cycle. 2003 Nov-Dec;2(6):579-84 [14512773.001]
  • [Cites] N Engl J Med. 2003 Nov 20;349(21):2042-54 [14627790.001]
  • [Cites] Endocr Relat Cancer. 2004 Jun;11(2):377-89 [15163312.001]
  • [Cites] Cancer. 2004 Jun 15;100(12):2543-8 [15197794.001]
  • [Cites] Nucleic Acids Res. 1986 May 27;14(10):4127-45 [3714473.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Dec;85(23):9302-6 [2848260.001]
  • [Cites] Mol Cell Biol. 1989 Mar;9(3):1083-91 [2725488.001]
  • [Cites] J Histochem Cytochem. 1990 Jan;38(1):31-9 [2294148.001]
  • [Cites] Genomics. 1990 Aug;7(4):594-601 [2387586.001]
  • [Cites] Exp Eye Res. 1992 Mar;54(3):461-70 [1381680.001]
  • [Cites] J Cell Biol. 1993 Feb;120(3):639-45 [8425893.001]
  • [Cites] Eur J Biochem. 1994 Oct 1;225(1):1-19 [7925426.001]
  • [Cites] J Pathol. 1994 Nov;174(3):209-15 [7823254.001]
  • [Cites] Hum Genet. 1996 Mar;97(3):299-303 [8786068.001]
  • [Cites] Cancer. 1995 Nov 1;76(9):1643-54 [8635070.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Jun 9;235(1):69-73 [9196037.001]
  • [Cites] J Cell Sci. 1997 Jul;110 ( Pt 13):1431-40 [9224761.001]
  • [Cites] Am J Physiol. 1998 May;274(5 Pt 2):H1457-64 [9612350.001]
  • [Cites] Genes Cells. 1998 Jul;3(7):443-57 [9753426.001]
  • [Cites] Am J Physiol. 1998 Dec;275(6 Pt 2):H2243-9 [9843825.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1999 Apr;40(5):951-8 [10102292.001]
  • [Cites] Prog Retin Eye Res. 1999 Jul;18(4):463-509 [10217480.001]
  • [Cites] Reproduction. 2005 Jan;129(1):115-26 [15615903.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1092-8 [15728570.001]
  • [Cites] Proteomics. 2005 Feb;5(3):788-95 [15682460.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1085-91 [15728569.001]
  • (PMID = 16184762.001).
  • [ISSN] 1355-8145
  • [Journal-full-title] Cell stress & chaperones
  • [ISO-abbreviation] Cell Stress Chaperones
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CRYAB protein, human; 0 / DNA, Complementary; 0 / HSP27 Heat-Shock Proteins; 0 / HSPB1 protein, human; 0 / Heat-Shock Proteins; 0 / Intermediate Filament Proteins; 0 / Neoplasm Proteins; 0 / Nerve Tissue Proteins; 0 / RNA, Messenger; 0 / Repressor Proteins; 0 / TFCP2L1 protein, human; 0 / Tissue Extracts; 0 / Transcription Factors; 0 / alpha-Crystallin B Chain; EC 1.13.12.- / Luciferases; EC 2.7.- / Protein Kinases
  • [Other-IDs] NLM/ PMC1226015
  •  go-up   go-down


32. Hirschbein MJ, Collins S, Jean WC, Chang SD, Adler JR Jr: Treatment of intraorbital lesions using the Accuray CyberKnife system. Orbit; 2008;27(2):97-105
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: This retrospective, non-comparative, interventional case series included 16 patients (6 women and 10 men) with lesions located wholly within the orbit.
  • Thirteen cases involved tumors (31% benign and 69% malignant), two cases presented with chronic orbital inflammation and one patient had intraorbital tissue growth secondary to Graves disease.
  • The main outcome measures analyzed were change in tumor/neoplasm size, pain, visual field preservation and visual acuity, which were followed for up to 15 months.
  • RESULTS: Twelve patients had a postoperative MRI, which revealed either a decrease or stabilization of tumor size.
  • In the five lymphoma cases there was complete disappearance of the tumor.
  • CONCLUSIONS: Staged CyberKnife radiosurgery is an effective option for the treatment of intraorbital lesions that controls tumor size, relieves pain, and preserves vision.
  • [MeSH-major] Orbital Neoplasms / radiotherapy. Orbital Neoplasms / surgery. Radiosurgery / instrumentation. Surgery, Computer-Assisted / instrumentation

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18415869.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contrast Media; 4419T9MX03 / Iohexol
  •  go-up   go-down


33. Charbel Issa P, Meyer-ter-Vehn T, Guthoff R, Klink T, Holz FG, Löffler K: [Malignant melanoma of the conjunctiva]. Klin Monbl Augenheilkd; 2008 Jul;225(7):663-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Malignant melanoma of the conjunctiva is a rare tumour.
  • Early disease stages may be difficult to distinguish from benign lesions such as pigmented nevi or primary acquired melanosis.
  • Two female patients (84 and 85 years old, respectively) presented with a pigmented tumor close to the limbus with surrounding conjunctival pigmentation and involvement of the cornea.
  • RESULTS: Following complete excision of the tumour, conjunctival malignant melanoma arising from primary acquired melanosis was diagnosed histologically.
  • Subsequent treatment with mitomycin C eye drops was initiated.
  • There was no recurrence of the tumor within the follow-up period (24 and 6 months).
  • [MeSH-major] Conjunctival Neoplasms / epidemiology. Conjunctival Neoplasms / pathology. Melanoma / epidemiology. Melanoma / pathology
  • [MeSH-minor] Aged, 80 and over. Diagnosis, Differential. Female. Humans. Incidence

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18642211.001).
  • [ISSN] 1439-3999
  • [Journal-full-title] Klinische Monatsblätter für Augenheilkunde
  • [ISO-abbreviation] Klin Monbl Augenheilkd
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


34. Naik VR, Wan Faiziah WA, Musa MY: Choristoma of the base of the tongue. Indian J Pathol Microbiol; 2009 Jan-Mar;52(1):86-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Choristoma is a benign tumor where new bone formation occurs.
  • These choristomas can rarely occur in soft tissues especially in the head, eye, tongue, or extremities.
  • [MeSH-major] Choristoma / diagnosis. Choristoma / pathology. Tongue / pathology. Tongue Neoplasms / diagnosis. Tongue Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Indian J Pathol Microbiol. 2010 Apr-Jun;53(2):373 [20551565.001]
  • (PMID = 19136792.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


35. Dimaras H, Gallie BL: The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development. Int J Cancer; 2008 May 01;122(9):2023-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development.
  • The transition from the benign retinal tumor retinoma to its malignant counterpart retinoblastoma is accompanied by the loss of expression of the p75(NTR) neurotrophin receptor.
  • We sought to determine the functional effect on tumor development of absence of p75(NTR) from the onset of TAg-RB tumor initiation.
  • The average tumor area per eye as a percentage of retinal area was measured.
  • TAg-RB/E3KO (TAg-RB(E3KO)) and heterozygous mice showed no significant difference in tumor area compared to the TAg-RB control mice at any time point studied.
  • However, TAg-RB/E4KO (TAg-RB(E4KO)) and heterozygous mice displayed a significantly larger tumor area than the TAg-RB control mice.
  • [MeSH-major] Receptor, Nerve Growth Factor / metabolism. Retinal Neoplasms / metabolism. Retinoblastoma / metabolism. Tumor Suppressor Proteins / metabolism
  • [MeSH-minor] Adenoviridae. Animals. Apoptosis. Caspase 3 / metabolism. Cell Line, Tumor. Cell Transformation, Neoplastic. Enzyme Activation. Fluorescent Antibody Technique. Gene Expression Regulation, Enzymologic. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. Mice. Neoplasms, Experimental / metabolism

  • Genetic Alliance. consumer health - Retinoblastoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18196575.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA118830
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptor, Nerve Growth Factor; 0 / Tumor Suppressor Proteins; EC 3.4.22.- / Caspase 3
  •  go-up   go-down


36. Houston SK, Bourne TD, Lopes MB, Ghazi NG: Bilateral massive retinal gliosis associated with retinopathy of prematurity. Arch Pathol Lab Med; 2009 Aug;133(8):1242-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Massive retinal gliosis (MRG) is a rare, benign intraocular condition that may develop in association with long-standing eye conditions including chronic inflammation, vascular disorders, glaucoma, trauma, or congenital abnormalities.
  • The differential diagnosis of MRG is discussed with specific emphasis on its relationship to vasoproliferative tumor of the retina and presumed acquired retinal hemangiomas.
  • In addition, we hypothesize that MRG, vasoproliferative tumor of the retina, and presumed acquired retinal hemangiomas may represent different phenotypes along a spectrum of the same disease process.
  • [MeSH-minor] Adult. Diagnosis, Differential. Eye Enucleation. Functional Laterality. Glial Fibrillary Acidic Protein / metabolism. Hemangioma / diagnosis. Humans. Infant, Newborn. Male. Retinal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Retinal Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19653718.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glial Fibrillary Acidic Protein
  •  go-up   go-down


37. Al-Khiary H, Ayoubi A, Elkhamary SM: Primary orbital ganglioneuroma in a 2-year-old healthy boy. Saudi J Ophthalmol; 2010 Jul;24(3):101-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He underwent orbital exploration via anterior orbitotomy incision and debulking of the tumor was done.
  • The histopathological examination confirmed the diagnosis of orbital ganglioneuroma.
  • Ganglioneuroma is an unusual benign tumor of neuroplastic origin with extremely rare orbital involvement with only one prior reported case in a youth.
  • The tumor is slow growing and non-metastasizing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23960884.001).
  • [ISSN] 1319-4534
  • [Journal-full-title] Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
  • [ISO-abbreviation] Saudi J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  • [Other-IDs] NLM/ PMC3729488
  • [Keywords] NOTNLM ; Ganglioneuroma / Neuroblastoma / Pediatric / Unilateral proptosis
  •  go-up   go-down


38. Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ, Johnson KR: Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol; 2008 Mar 24;180(6):1277-89
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor cells undergo epithelial-to-mesenchymal transition (EMT) to convert from a benign to a malignant phenotype.
  • We have shown that human pancreatic cancer cells respond to collagen by up-regulating N-cadherin, which promotes tumor growth, invasion, and metastasis.
  • Initial characterization showed that knocking down c-Jun NH2-terminal kinase prevented N-cadherin up-regulation and limited tumor growth and invasion in a mouse model for pancreatic cancer.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2002 Feb 15;295(5558):1285-8 [11847339.001]
  • [Cites] Nat Cell Biol. 2002 Apr;4(4):E83-90 [11944041.001]
  • [Cites] Am J Pathol. 2002 Jun;160(6):2001-8 [12057905.001]
  • [Cites] BMC Cell Biol. 2002 Jul 15;3:18 [12119061.001]
  • [Cites] Nat Rev Cancer. 2002 Jun;2(6):442-54 [12189386.001]
  • [Cites] J Biol Chem. 2002 Sep 6;277(36):32970-7 [12087088.001]
  • [Cites] Cell. 2002 Sep 20;110(6):673-87 [12297042.001]
  • [Cites] J Cell Biol. 2002 Nov 11;159(3):465-76 [12427869.001]
  • [Cites] Cancer Res. 2002 Nov 15;62(22):6688-97 [12438268.001]
  • [Cites] Dev Cell. 2003 Jan;4(1):11-8 [12530959.001]
  • [Cites] Cell. 2003 Mar 7;112(5):673-84 [12628187.001]
  • [Cites] J Biol Chem. 2003 May 9;278(19):17269-76 [12604612.001]
  • [Cites] Cell. 2003 Jun 13;113(6):685-700 [12809600.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Aug;4(8):657-65 [12923528.001]
  • [Cites] J Biol Chem. 2003 Nov 14;278(46):45801-10 [12954618.001]
  • [Cites] Curr Opin Cell Biol. 2003 Dec;15(6):740-6 [14644200.001]
  • [Cites] J Am Soc Nephrol. 2004 Jan;15(1):1-12 [14694152.001]
  • [Cites] Front Biosci. 2004 May 1;9:1254-66 [14977542.001]
  • [Cites] Trends Biochem Sci. 2004 May;29(5):265-73 [15130563.001]
  • [Cites] Cancer Res. 1998 Jan 1;58(1):14-9 [9426049.001]
  • [Cites] J Biol Chem. 1998 Jan 16;273(3):1281-4 [9430657.001]
  • [Cites] Trends Cell Biol. 1998 Apr;8(4):151-7 [9695829.001]
  • [Cites] J Cell Biol. 1998 Nov 30;143(5):1385-98 [9832565.001]
  • [Cites] Biochim Biophys Acta. 2004 Jul 5;1692(2-3):63-76 [15246680.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31041-9 [15143071.001]
  • [Cites] J Cell Biol. 2004 Jul 19;166(2):283-95 [15263022.001]
  • [Cites] J Biol Chem. 2004 Aug 6;279(32):33315-22 [15166227.001]
  • [Cites] Oncogene. 2004 Aug 5;23(35):5978-85 [15184866.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35127-32 [15166221.001]
  • [Cites] J Cell Sci. 2004 Sep 15;117(Pt 20):4691-703 [15331629.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26 [15459662.001]
  • [Cites] J Cell Biol. 2004 Oct 11;167(1):111-22 [15479739.001]
  • [Cites] Respir Res. 2006;7:114 [16948840.001]
  • [Cites] Exp Eye Res. 2006 Dec;83(6):1309-16 [16769055.001]
  • [Cites] Microbiol Mol Biol Rev. 2006 Dec;70(4):1061-95 [17158707.001]
  • [Cites] Cancer Res. 2006 Dec 15;66(24):11745-53 [17178870.001]
  • [Cites] J Cell Sci. 2007 Jan 1;120(Pt 1):17-22 [17182900.001]
  • [Cites] J Am Soc Nephrol. 2007 Mar;18(3):846-59 [17267741.001]
  • [Cites] Cell Signal. 2007 May;19(5):923-31 [17197157.001]
  • [Cites] Cancer Res. 2007 Apr 1;67(7):3106-16 [17409417.001]
  • [Cites] Int J Cancer. 2008 Jan 1;122(1):71-7 [17721921.001]
  • [Cites] Am J Respir Cell Mol Biol. 2008 Jan;38(1):95-104 [17673689.001]
  • [Cites] J Cell Biol. 1999 Nov 1;147(3):631-44 [10545506.001]
  • [Cites] J Biol Chem. 2000 Feb 25;275(8):5779-84 [10681566.001]
  • [Cites] J Cell Biol. 2000 Feb 21;148(4):779-90 [10684258.001]
  • [Cites] J Cell Biol. 2000 Mar 20;148(6):1151-8 [10725328.001]
  • [Cites] Cancer Res. 2000 Jul 1;60(13):3650-4 [10910081.001]
  • [Cites] Curr Biol. 2000 Aug 24;10(16):974-8 [10985384.001]
  • [Cites] Cancer Res. 2001 Apr 15;61(8):3508-17 [11309315.001]
  • [Cites] Am J Pathol. 2001 Oct;159(4):1313-21 [11583959.001]
  • [Cites] Bioessays. 2001 Oct;23(10):912-23 [11598958.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5192-6 [1594631.001]
  • [Cites] J Cell Biol. 1993 May;121(3):673-8 [8387531.001]
  • [Cites] Exp Cell Res. 1993 Aug;207(2):252-60 [8344378.001]
  • [Cites] Exp Cell Res. 1994 Apr;211(2):175-82 [8143763.001]
  • [Cites] Pancreas. 1995 Nov;11(4):357-64 [8532652.001]
  • [Cites] J Biol Chem. 1996 Mar 22;271(12):6794-800 [8636102.001]
  • [Cites] J Cell Biol. 1996 Dec;135(6 Pt 1):1643-54 [8978829.001]
  • [Cites] Cancer Res. 1999 Feb 15;59(4):947-52 [10029089.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2805-10 [10077592.001]
  • [Cites] J Biol Chem. 1999 May 21;274(21):14893-901 [10329689.001]
  • [Cites] J Biol Chem. 1999 Oct 8;274(41):28966-71 [10506143.001]
  • [Cites] Clin Cancer Res. 2004 Nov 1;10(21):7427-37 [15534120.001]
  • [Cites] J Cell Sci. 2005 Mar 1;118(Pt 5):873-87 [15713751.001]
  • [Cites] Cell Oncol. 2005;27(1):3-13 [15750203.001]
  • [Cites] Science. 2005 Mar 11;307(5715):1603-9 [15761148.001]
  • [Cites] Science. 2005 Mar 11;307(5715):1621-5 [15761153.001]
  • [Cites] Curr Opin Cell Biol. 2005 Apr;17(2):123-8 [15780587.001]
  • [Cites] Gastroenterology. 2005 Apr;128(4):907-21 [15825074.001]
  • [Cites] Nature. 2005 Jul 7;436(7047):123-7 [16001073.001]
  • [Cites] J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84 [16105881.001]
  • [Cites] Oncogene. 2005 Aug 29;24(37):5764-74 [16123809.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):898-906 [16424023.001]
  • [Cites] Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42 [16493418.001]
  • [Cites] Oncogene. 2006 Mar 2;25(9):1378-90 [16247454.001]
  • [Cites] J Cell Biol. 2006 Mar 27;172(7):973-81 [16567498.001]
  • [Cites] Cancer Res. 2006 May 1;66(9):4662-71 [16651417.001]
  • [Cites] Br J Cancer. 2006 May 8;94(9):1311-9 [16622460.001]
  • [Cites] Cell Signal. 2006 Aug;18(8):1108-16 [16626936.001]
  • [Cites] Trends Cell Biol. 2006 May;16(5):257-63 [16581250.001]
  • [Cites] Mol Biol Cell. 2006 Jul;17(7):2963-75 [16624865.001]
  • [Cites] Hepatogastroenterology. 2001 Sep-Oct;48(41):1321-7 [11677955.001]
  • [Cites] Cancer Lett. 2002 Feb 25;176(2):123-8 [11804738.001]
  • (PMID = 18362184.001).
  • [ISSN] 1540-8140
  • [Journal-full-title] The Journal of cell biology
  • [ISO-abbreviation] J. Cell Biol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01-GM51188; United States / NIDCR NIH HHS / DE / R01-DE12308; United States / NIDCR NIH HHS / DE / R01 DE012308; United States / NCI NIH HHS / CA / P30 CA036727; United States / NCI NIH HHS / CA / P30 CA36727; United States / NIGMS NIH HHS / GM / R01 GM051188
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BCAR1 protein, human; 0 / Cadherins; 0 / Collagen Type I; 0 / Crk-Associated Substrate Protein; 0 / Integrin alpha2beta1; 0 / Receptors, Mitogen; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / discoidin receptor; EC 2.7.10.2 / Focal Adhesion Kinase 2; EC 2.7.10.2 / Focal Adhesion Protein-Tyrosine Kinases; EC 3.6.5.2 / rap1 GTP-Binding Proteins
  • [Other-IDs] NLM/ PMC2290851
  •  go-up   go-down


39. Jakobiec FA, Nguyen J, Bhat P, Fay A: MDM2-positive atypical lipomatous neoplasm/well-differentiated liposarcoma versus spindle cell lipoma of the orbit. Ophthal Plast Reconstr Surg; 2010 Nov-Dec;26(6):413-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MDM2-positive atypical lipomatous neoplasm/well-differentiated liposarcoma versus spindle cell lipoma of the orbit.
  • PURPOSE: To distinguish, in a 36-year-old man, an atypical lipomatous neoplasm/well-differentiated liposarcoma from a spindle cell lipoma in a recurrent orbital tumor.
  • RESULTS: MDM2 gene amplification was discovered in the CD34 tumor cells.
  • These findings established the diagnosis of a well-differentiated liposarcoma with lipoma-like and spindle cell features and ruled out a spindle cell lipoma.
  • CONCLUSION: Well-differentiated liposarcoma is a slow growing, infiltrative, and nonmetastasizing neoplasm that is microscopically and diagnostically challenging.
  • It can be reliably separated from a benign spindle cell or an atypical lipoma by using the markers MDM2 and Ki-67.
  • [MeSH-major] Biomarkers, Tumor / analysis. Lipoma / diagnosis. Liposarcoma / diagnosis. Orbital Neoplasms / diagnosis. Proto-Oncogene Proteins c-mdm2 / analysis

  • Genetic Alliance. consumer health - Liposarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20639786.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD34; 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / S100 Proteins; 9013-56-3 / Factor XIII; EC 6.3.2.19 / MDM2 protein, human; EC 6.3.2.19 / Proto-Oncogene Proteins c-mdm2
  •  go-up   go-down


40. Murthy R, Honavar SG: Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1. J AAPOS; 2009 Feb;13(1):97-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1.
  • Vasoproliferative retinal tumors are benign tumors of unknown origin that generally affect healthy persons between their fourth and sixth decades and may lead to severe vision loss as a result of intraretinal hemorrhages and exudates.
  • We describe a case of unilateral vasoproliferative retinal tumor associated with retinitis pigmentosa in a patient with Usher syndrome type 1.


41. Roberts DS, Faquin WC, Deschler DG: Giant cell tumors of the temporal bone and infratemporal fossa: a case report and review of the literature. Laryngoscope; 2010;120 Suppl 4:S180
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To report a giant cell tumor (GCT) of temporal bone and infratemporal fossa and to review the literature pertinent to the care of such patients.
  • RESULTS: Six case reports over 23 years illustrate that these benign locally destructive lesions may originate in the temporal bone with extension into the infratemporal fossa.
  • [MeSH-major] Bone Neoplasms / surgery. Giant Cell Tumor of Bone / surgery. Temporal Bone / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21225778.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


42. Hazzaa SM, Elashry OM, Afifi IK: Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol Oncol Res; 2010 Mar;16(1):101-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Blood and urine samples were used from 68 patients with TCC of the bladder and from 61 patients with benign urological diseases.
  • Quantitation of clusterin mRNA was carried out in 68 bladder tumor specimens from radical cystectomy or transurethral resection and 26 normal bladder specimens from BPH patients by using RT-PCR method.
  • Sensitivity and specificity of serum and urine clusterin as a tumor marker for TCC of the bladder was found to be 80%, 91%, 87.1% and 96.7% respectively.
  • Overexpression of clusterin mRNA was significantly associated with tumor recurrence and overall survival (p < 0.001).
  • [MeSH-major] Biomarkers, Tumor / analysis. Carcinoma, Transitional Cell / diagnosis. Clusterin / biosynthesis. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Adult. Enzyme-Linked Immunosorbent Assay. Female. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Transitional cell carcinoma.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2003 Mar 28;278(13):11590-600 [12551933.001]
  • [Cites] Pancreas. 2002 Oct;25(3):234-8 [12370533.001]
  • [Cites] Trends Biochem Sci. 1992 Apr;17(4):154-9 [1585460.001]
  • [Cites] Am J Surg Pathol. 1998 Dec;22(12):1435-48 [9850170.001]
  • [Cites] J Urol. 2001 May;165(5):1481-7 [11342901.001]
  • [Cites] World J Urol. 2008 Feb;26(1):1-3 [18060549.001]
  • [Cites] Mol Cancer Ther. 2004 Mar;3(3):223-32 [15026542.001]
  • [Cites] Cell Death Differ. 2006 Jan;13(1):12-9 [16179938.001]
  • [Cites] J Biol Chem. 1983 Jun 25;258(12):7714-20 [6863260.001]
  • [Cites] Urology. 2006 Jan;67(1):105-9 [16413343.001]
  • [Cites] Diagn Cytopathol. 1995 Oct;13(3):214-23; discussion 224 [8575280.001]
  • [Cites] Clin Cancer Res. 1997 Oct;3(10):1707-11 [9815554.001]
  • [Cites] Int J Biochem Cell Biol. 2002 May;34(5):427-31 [11906815.001]
  • [Cites] Prostate. 2004 Dec 1;61(4):318-23 [15389725.001]
  • [Cites] Clin Cancer Res. 2000 May;6(5):1655-63 [10815883.001]
  • [Cites] Am J Pathol. 2000 Aug;157(2):393-9 [10934144.001]
  • [Cites] Curr Eye Res. 2001 Sep;23 (3):157-65 [11803476.001]
  • [Cites] Oncogene. 2004 Mar 25;23(13):2298-304 [14755245.001]
  • [Cites] Neoplasma. 2006;53(4):343-6 [16830064.001]
  • [Cites] Int J Cancer. 2004 Jan 1;108(1):23-30 [14618611.001]
  • [Cites] Cancer Res. 2000 May 1;60(9):2547-54 [10811138.001]
  • [Cites] Cancer Res. 2004 Mar 1;64(5):1834-42 [14996747.001]
  • [Cites] Mod Pathol. 2002 Nov;15(11):1221-6 [12429802.001]
  • [Cites] J Cancer Res Clin Oncol. 1994;120(3):186-8 [8263017.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9530-5 [12886021.001]
  • [Cites] World J Gastroenterol. 2003 Apr;9(4):650-4 [12679903.001]
  • [Cites] Urology. 2002 Jan;59(1):150-4 [11796313.001]
  • [Cites] World J Urol. 2005 Feb;23(1):38-46 [15770517.001]
  • [Cites] BJU Int. 2003 Sep;92(4):463-9 [12930442.001]
  • [Cites] Int J Urol. 2001 Jul;8(7):337-49 [11442654.001]
  • [Cites] Cell Res. 2003 Feb;13(1):49-58 [12643349.001]
  • [Cites] Clin Cancer Res. 2001 Dec;7(12):4245-52 [11751526.001]
  • [Cites] J Urol. 2000 Sep;164(3 Pt 1):680-4 [10954628.001]
  • (PMID = 19757199.001).
  • [ISSN] 1532-2807
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Clusterin
  •  go-up   go-down


43. Ethmoidal osteoid osteoma with orbital and intracranial extension - a case report. BMC Ear Nose Throat Disord; 2005 Mar 11;5:2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Osteoid osteoma is a benign bone neoplasm which is seen in the long bones of appendicular skeleton.
  • He presented with loss of vision in the left eye.
  • Radical excision of the tumor could thus be achieved through a craniofacial approach.
  • CONCLUSION: Although benign and rare, skull base osteoid osteoma can present with neurological deficit due to its mass effect and involvement of vital structures.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Neurosurg. 1998 Apr;12(2):173-5 [11013675.001]
  • [Cites] Am J Clin Pathol. 1975 Mar;63(3):391-6 [1115044.001]
  • [Cites] J Laryngol Otol. 1989 Jun;103(6):634-7 [2769039.001]
  • (PMID = 15760476.001).
  • [ISSN] 1472-6815
  • [Journal-full-title] BMC ear, nose, and throat disorders
  • [ISO-abbreviation] BMC Ear Nose Throat Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC555567
  •  go-up   go-down


44. Amoli FA, Mehrabani PM, Tari AS: Aggressive orbital optic nerve meningioma with benign microscopic features: a case report. Orbit; 2007 Dec;26(4):271-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive orbital optic nerve meningioma with benign microscopic features: a case report.
  • The patient had a history of orbital meningioma from 10 years ago and several surgical resections due to tumor recurrence during these 10 years.
  • Fine-needle aspiration cytology of the mass confirmed tumor recurrence.
  • The patient first received radiotherapy due to the inoperable mass, and the tumor was resected 1.5 month later.
  • The interesting aspect of this case was the aggressive behavior of the tumor with intraocular invasion, despite its benign histopathological features, which led to wide exenteration of the eye together with resection of the upper and lower lids.
  • [MeSH-major] Meningioma / pathology. Optic Nerve Neoplasms / pathology
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18097966.001).
  • [ISSN] 0167-6830
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


45. Nuruddin M, Osmani M, Mudhar HS, Fernando M: Orbital lipofibromatosis in a child: a case report. Orbit; 2010 Dec;29(6):360-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Lipofibromatosis is a rare, benign, soft tissue tumor that typically involves extremities particularly in children.
  • Histopathological examination revealed that the lesion consisted of adipose tissue with fibroblastic elements, being consistent with a diagnosis of lipofibromatosis.
  • Diagnosis can be confirmed by histopathological analysis.
  • [MeSH-major] Fibroma / pathology. Lipoma / pathology. Orbital Neoplasms / pathology. Orbital Neoplasms / surgery
  • [MeSH-minor] Biopsy, Needle. Blepharoptosis / diagnosis. Blepharoptosis / etiology. Child. Female. Follow-Up Studies. Humans. Immunohistochemistry. Ophthalmologic Surgical Procedures / methods. Rare Diseases. Tomography, X-Ray Computed / methods. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21158580.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


46. Kim BH, Henderson BA: Intraocular choristoma. Semin Ophthalmol; 2005 Oct-Dec;20(4):223-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although it is regarded as a benign tumor, it grows progressively and can decrease visual function.
  • [MeSH-major] Choristoma / diagnosis. Eye Diseases / diagnosis
  • [MeSH-minor] Animals. Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16352493.001).
  • [ISSN] 0882-0538
  • [Journal-full-title] Seminars in ophthalmology
  • [ISO-abbreviation] Semin Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 54
  •  go-up   go-down


47. Jakobiec FA, Bhat P, Colby KA: Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol; 2010 Feb;128(2):174-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To evaluate the role of immunohistochemical methods in the diagnosis of benign and malignant conjunctival melanocytic proliferations.
  • CONCLUSIONS: S-100 and MART-1 were not useful in separating benign from malignant lesions.
  • Immunostaining for HMB-45 and Ki-67 are valuable adjuncts to careful histopathologic evaluation in assessing benign and malignant conjunctival melanocytic tumors.
  • [MeSH-major] Biomarkers, Tumor / analysis. Conjunctival Neoplasms / diagnosis. Melanoma / diagnosis. Neoplasm Proteins / analysis. Nevus, Pigmented / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD45 / analysis. Antigens, Neoplasm / analysis. Child. Diagnosis, Differential. Female. Humans. Immunoenzyme Techniques. Ki-67 Antigen / analysis. MART-1 Antigen. Male. Melanoma-Specific Antigens. Middle Aged. Retrospective Studies. S100 Proteins / analysis. Young Adult

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20142539.001).
  • [ISSN] 1538-3601
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins; EC 3.1.3.48 / Antigens, CD45; EC 3.1.3.48 / PTPRC protein, human
  •  go-up   go-down


48. Stone DU, Chodosh J: Epibulbar nodular fasciitis associated with floppy eyelids. Cornea; 2005 Apr;24(3):361-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The clinical examination revealed floppy eyelids and an epibulbar mass in the right eye.
  • CONCLUSIONS: Nodular fasciitis is a rare, benign, soft-tissue tumor that has not been previously reported in association with floppy eyelids.
  • The cause of both disorders is thought to be repetitive trauma, suggesting that eye rubbing may be a common underlying etiology.
  • [MeSH-major] Eyelid Diseases / diagnosis. Eyelids / pathology. Fasciitis / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Eyelid Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15778617.001).
  • [ISSN] 0277-3740
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


49. Finn M, Krohne S, Stiles J: Ocular melanocytic neoplasia. Compend Contin Educ Vet; 2008 Jan;30(1):19-25; quiz 26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ocular melanocytic neoplasia.
  • Tumors of melanocytic origin in ocular tissues are relatively uncommon in dogs and cats, and although many are benign, some have a high potential for metastasis.
  • In addition, even small ocular masses can be significant due to their potential vision-threatening sequelae.
  • While several similarities exist among these tumors, the prognosis and recommended treatment options vary based on the species affected as well as the location, extent, and histologic characteristics of the tumor.
  • [MeSH-major] Cat Diseases / diagnosis. Dog Diseases / diagnosis. Eye Neoplasms / veterinary. Melanoma / veterinary

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18278744.001).
  • [ISSN] 1940-8315
  • [Journal-full-title] Compendium (Yardley, PA)
  • [ISO-abbreviation] Compend Contin Educ Vet
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


50. Yates CW, Weinberg M, Packer MJ, Jacob A: Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma. Ann Otol Rhinol Laryngol; 2010 Jun;119(6):402-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma.
  • Vestibular schwannomas are benign neoplasms that arise from Schwann cells of the eighth cranial nerve.
  • During this procedure, a biopsy specimen was obtained, showing benign vestibular schwannoma.

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. WARFARIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20583739.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 5Q7ZVV76EI / Warfarin
  •  go-up   go-down


51. Paglia D, Dubielzig RR, Kado-Fong HK, Maggs DJ: Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms. Am J Vet Res; 2009 Oct;70(10):1284-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.
  • OBJECTIVE: To determine whether cyclooxygenase-2 (COX-2) is expressed in benign or malignant canine uveal melanocytic neoplasms and whether expression correlates with malignancy.
  • SAMPLE POPULATION: Tissue sections from 71 globes; 57 with benign (n = 15), malignant (34), or mixed (8) uveal melanocytic neoplasms; 10 with nonneoplastic disease; and 4 with no abnormalities.
  • RESULTS: Expression of COX-2 was detected in all but 5 globes, all of which contained neoplasms.
  • Expression of COX-2 was detected in regions infiltrated by neoplasia in 21 globes; however, definitive labeling of tumor cells was detected in only 2 of those.
  • Expression of COX-2 was detected in the ciliary body of more globes with uveal malignant melanoma (20/34) than in those without disease (1/4), with nonneoplastic disease (4/10), or with melanocytoma (3/15) or mixed neoplasms (3/8).
  • CONCLUSIONS AND CLINICAL RELEVANCE: Canine globes with uveal melanocytic neoplasia appeared to express COX-2 in similar sites and with similar intensity as globes without neoplasia.
  • Differentiation of benign from malignant canine uveal melanocytic neoplasms was not possible.
  • [MeSH-major] Cyclooxygenase 2 / metabolism. Dog Diseases / metabolism. Eye Neoplasms / veterinary. Uvea / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19795944.001).
  • [ISSN] 0002-9645
  • [Journal-full-title] American journal of veterinary research
  • [ISO-abbreviation] Am. J. Vet. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


52. Sampieri K, Amenduni M, Papa FT, Katzaki E, Mencarelli MA, Marozza A, Epistolato MC, Toti P, Lazzi S, Bruttini M, De Filippis R, De Francesco S, Longo I, Meloni I, Mari F, Acquaviva A, Hadjistilianou T, Renieri A, Ariani F: Array comparative genomic hybridization in retinoma and retinoblastoma tissues. Cancer Sci; 2009 Mar;100(3):465-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In retinoblastoma, two RB1 mutations are necessary for tumor development.
  • Array-comparative genomic hybridization was carried out in 18 eye samples, 10 from bilateral and eight from unilateral retinoblastoma patients.
  • The first group presented with younger age at diagnosis (mean 511 days) compared with the second group (mean 1606 days).
  • In one retinoma case ophthalmoscopically diagnosed as a benign lesion no rearrangements were detected, whereas the adjacent retinoblastoma displayed seven aberrations.
  • Genomic profiling indicated that the first retinoma was a pretumoral lesion, whereas the other represents a subclone of cells bearing 'benign' rearrangements overwhelmed by another subclone presenting aberrations with higher 'oncogenic' potential.
  • In summary, the present study shows that bilateral and unilateral retinoblastoma have different chromosomal instability that correlates with the age of tumor onset in unilateral cases.
  • [MeSH-major] Genes, Retinoblastoma. Retinal Neoplasms / genetics. Retinoblastoma / genetics. Retinoblastoma Protein / genetics

  • Genetic Alliance. consumer health - Retinoblastoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19183342.001).
  • [ISSN] 1349-7006
  • [Journal-full-title] Cancer science
  • [ISO-abbreviation] Cancer Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Anti-Idiotypic; 0 / Retinoblastoma Protein
  •  go-up   go-down


53. Jakobiec FA, Nguyen J, Bhat P, Fay A: Recurrent blue nevus of the corneoscleral limbus. Cornea; 2010 Aug;29(8):947-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Ki-67 proliferation index was very low (0.05%), supporting a benign diagnosis.
  • CONCLUSIONS: Careful histopathological and immunohistochemical evaluation of recurrent, incompletely excised, blue nevi can determine if they remain benign.
  • [MeSH-major] Corneal Diseases / surgery. Eye Neoplasms / surgery. Neoplasm Recurrence, Local. Nevus, Blue / surgery. Scleral Diseases / surgery
  • [MeSH-minor] Adolescent. Biomarkers, Tumor / analysis. Cryotherapy. Female. Humans. Sclerostomy

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20508501.001).
  • [ISSN] 1536-4798
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


54. Farmer JP, Lamba M, McDonald H, Commons AS: Orbital giant cell angiofibroma: immuno-histochemistry and differential diagnosis. Can J Ophthalmol; 2006 Apr;41(2):216-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orbital giant cell angiofibroma: immuno-histochemistry and differential diagnosis.
  • COMMENTS: Giant cell angiofibroma is a benign spindle cell neoplasm characterized by multinucleated giant cells and pseudovascular spaces with a propensity to occur in the anterior soft tissues of the orbit of middle-aged adults.
  • It is part of a wide differential diagnosis of tumours that can be separated by various histologic and immunohistochemical features, which are discussed in the report.
  • It is important to consider it preoperatively because the vascular nature of this tumour may create problems with hemostasis during excision.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16767212.001).
  • [ISSN] 0008-4182
  • [Journal-full-title] Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
  • [ISO-abbreviation] Can. J. Ophthalmol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


55. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J: Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature. Strahlenther Onkol; 2006 Nov;182(11):635-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
  • PURPOSE: To analyze own long-term results with fractionated stereotactic radiotherapy (FSRT) in patients with benign meningiomas of the cavernous sinus and to review the literature on these rare lesions.
  • PATIENTS AND METHODS: 57 patients were treated with FSRT for benign meningiomas of the cavernous sinus between 01/1990 and 12/2003 at the authors' institution.
  • Overall local tumor control was 100%.
  • 39/57 patients had stable disease based on CT/MRI, while 18/57 had a partial remission of tumor volume.
  • There was one patient with recurrent hyperlacrimation of one eye on the side of the irradiated meningioma.
  • CONCLUSION: These data demonstrate that FSRT is an effective and safe treatment modality for local control of benign cavernous sinus meningiomas with a minimal risk of significant late toxicity.
  • [MeSH-major] Cavernous Sinus. Dose Fractionation. Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy
  • [MeSH-minor] Follow-Up Studies. Humans. Magnetic Resonance Imaging. Neoplasm Recurrence, Local / radiotherapy. Radiosurgery. Radiotherapy Dosage. Radiotherapy Planning, Computer-Assisted. Remission Induction. Safety. Stereotaxic Techniques. Time Factors. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17072520.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 43
  •  go-up   go-down


56. Jagannathan J, Oskouian RJ, Yeoh HK, Saulle D, Dumont AS: Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base; 2008 May;18(3):173-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Even though meningiomas are most often benign tumors, they can be locally invasive and can develop in locations that prevent surgical treatment.
  • Although the relationship between the various factors implicated in tumor development is unknown, understanding these factors will be critical in the treatment of malignant or surgically inaccessible tumors.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurochirurgie. 1966 May-Jun;12(3):361-71 [5962139.001]
  • [Cites] Humangenetik. 1975 Dec 23;30(4):343-8 [1218864.001]
  • [Cites] J Clin Endocrinol Metab. 1970 Aug;31(2):180-98 [4912771.001]
  • [Cites] Humangenetik. 1971;12(1):42-9 [5283371.001]
  • [Cites] Humangenetik. 1975;27(2):119-28 [1150234.001]
  • [Cites] Humangenetik. 1971;11(3):253-7 [5101664.001]
  • [Cites] Neuropathology. 2006 Dec;26(6):557-63 [17203593.001]
  • [Cites] Cancer Invest. 2006 Dec;24(8):727-33 [17162554.001]
  • [Cites] Expert Rev Neurother. 2006 Oct;6(10):1447-64 [17078786.001]
  • [Cites] Hum Pathol. 1998 Nov;29(11):1200-7 [9824096.001]
  • [Cites] Cancer Res. 1998 Aug 1;58(15):3226-30 [9699646.001]
  • [Cites] Cancer. 1998 Jun 1;82(11):2262-9 [9610708.001]
  • [Cites] J Neurosurg. 1998 May;88(5):870-3 [9576256.001]
  • [Cites] J Neurosurg. 1998 May;88(5):831-9 [9576250.001]
  • [Cites] Hum Pathol. 1998 Feb;29(2):140-5 [9490273.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] Cancer Res. 1998 Jan 1;58(1):29-33 [9426052.001]
  • [Cites] Acta Neuropathol. 1997 Nov;94(5):479-85 [9386781.001]
  • [Cites] J Pathol. 1997 Aug;182(4):380-4 [9306957.001]
  • [Cites] J Neurosurg. 1997 Sep;87(3):368-73 [9285600.001]
  • [Cites] Neurosurgery. 1997 Jun;40(6):1269-77 [9179901.001]
  • [Cites] Hum Pathol. 1997 Jul;28(7):779-85 [9224744.001]
  • [Cites] Neurosurgery. 1997 May;40(5):1016-26 [9149260.001]
  • [Cites] Hum Pathol. 1997 Apr;28(4):416-20 [9104940.001]
  • [Cites] Neurosurgery. 1997 Feb;40(2):271-5 [9007858.001]
  • [Cites] Oncogene. 1997 Feb 6;14(5):611-6 [9053860.001]
  • [Cites] J Neurosurg. 1997 Jan;86(1):113-20 [8988089.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:50-3 [8738495.001]
  • [Cites] Hum Genet. 1996 May;97(5):638-41 [8655145.001]
  • [Cites] Anticancer Res. 1996 Mar-Apr;16(2):717-23 [8687119.001]
  • [Cites] Cancer Genet Cytogenet. 1996 Nov;92(1):73-8 [8956876.001]
  • [Cites] Hum Genet. 1996 May;97(5):632-7 [8655144.001]
  • [Cites] Neurosurgery. 1995 Nov;37(5):937-46; discussion 946-7 [8559343.001]
  • [Cites] Cancer Genet Cytogenet. 1995 Sep;83(2):160-4 [7553588.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] Neurosurgery. 1995 Feb;36(2):365-73; discussion 373-4 [7731518.001]
  • [Cites] J Neurosurg. 1994 Sep;81(3):388-93 [8057146.001]
  • [Cites] Int J Cancer. 1995 Aug 22;64(4):223-8 [7657383.001]
  • [Cites] Biochem Pharmacol. 1987 Jul 1;36(13):2115-23 [3606629.001]
  • [Cites] J Neurosurg. 1985 Jan;62(1):18-24 [3964853.001]
  • [Cites] Int J Cancer. 1990 Jul 15;46(1):16-21 [2163990.001]
  • [Cites] J Neurosurg. 1990 May;72(5):786-91 [2182793.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(15):5710-4 [2377607.001]
  • [Cites] J Neurosurg. 1990 Aug;73(2):248-53 [2366081.001]
  • [Cites] Humangenetik. 1970;9(2):172-84 [5423930.001]
  • [Cites] Eye (Lond). 2004 Sep;18(9):954-8 [15037887.001]
  • [Cites] Neuropathology. 2003 Dec;23(4):275-81 [14719542.001]
  • [Cites] J Neurosurg. 2003 Oct;99(4):787-91 [14567620.001]
  • [Cites] Clin Cancer Res. 2003 Oct 1;9(12):4443-51 [14555517.001]
  • [Cites] Brain Pathol. 2001 Jul;11(3):296-305 [11414472.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Jun;60(6):628-36 [11398839.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1117-26 [11342575.001]
  • [Cites] Int J Cancer. 2001 May 15;92(4):551-4 [11304690.001]
  • [Cites] J Neurooncol. 2000 Dec;50(3):207-13 [11263500.001]
  • [Cites] J Neurosurg. 2001 Mar;94(3):487-92 [11235955.001]
  • [Cites] J Neurosurg. 2001 Jan;94(1):111-7 [11147878.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Oct;59(10):872-9 [11079777.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(5):493-505 [10898356.001]
  • [Cites] Hum Mol Genet. 2000 Jun 12;9(10):1495-500 [10888600.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Jul;59(7):614-20 [10901233.001]
  • [Cites] Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8 [10764269.001]
  • [Cites] Neurosurgery. 2000 Mar;46(3):692-702; discussion 702-3 [10719866.001]
  • [Cites] Neuropathol Appl Neurobiol. 2000 Feb;26(1):67-75 [10736068.001]
  • [Cites] N Engl J Med. 2000 Apr 20;342(16):1171-7 [10770982.001]
  • [Cites] Cancer. 1999 Dec 15;86(12):2649-58 [10594860.001]
  • [Cites] Int J Oncol. 2006 Jul;29(1):25-32 [16773181.001]
  • [Cites] Int J Oncol. 2006 Jun;28(6):1353-60 [16685436.001]
  • [Cites] Cancer Res. 2005 Aug 15;65(16):7121-6 [16103061.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Neurosurgery. 1999 Mar;44(3):579-87; discussion 587-8 [10069595.001]
  • [Cites] Cancer Res. 1995 Mar 1;55(5):1189-93 [7532545.001]
  • [Cites] Brain Pathol. 1995 Jan;5(1):11-4 [7767486.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):827-32 [7717450.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Apr 17;209(2):497-505 [7733917.001]
  • [Cites] Hum Genet. 1995 Mar;95(3):347-51 [7868131.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Apr;9(4):296-8 [7519053.001]
  • [Cites] Ophthalmologica. 1994;208(4):220-5 [7970552.001]
  • [Cites] Mol Carcinog. 1993;8(2):74-80 [8397797.001]
  • [Cites] J Neurosurg. 1993 Mar;78(3):456-62 [8433149.001]
  • [Cites] Childs Nerv Syst. 1991 Dec;7(8):432-6 [1665101.001]
  • [Cites] Semin Cancer Biol. 1992 Apr;3(2):89-96 [1378314.001]
  • [Cites] Cancer. 1992 Sep 15;70(6):1568-76 [1516008.001]
  • [Cites] Cancer Res. 1991 Nov 15;51(22):6202-5 [1933879.001]
  • [Cites] Cancer. 1991 Sep 15;68(6):1394-400 [1873791.001]
  • [Cites] Aust N Z J Surg. 1989 Nov;59(11):881-8 [2818349.001]
  • [Cites] Cancer. 1988 Nov 15;62(10):2139-44 [3052782.001]
  • [Cites] Cell. 1987 Jun 5;49(5):589-94 [2884037.001]
  • [Cites] J Med Genet. 1987 Sep;24(9):529-30 [3118032.001]
  • [Cites] Science. 1987 Apr 17;236(4799):317-9 [3105060.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2243-9 [2804914.001]
  • [Cites] Hereditas. 1984;101(1):103-13 [6490389.001]
  • [Cites] J Clin Oncol. 2003 Sep 1;21(17):3285-95 [12947064.001]
  • [Cites] Cancer Control. 2003 Mar-Apr;10(2):148-58 [12712009.001]
  • [Cites] Int J Cancer. 2003 May 10;104(6):728-34 [12640680.001]
  • [Cites] Cancer Causes Control. 2002 Sep;13(7):675-82 [12296515.001]
  • [Cites] J Neurosurg. 2002 Aug;97(2):441-9 [12186474.001]
  • [Cites] Neoplasia. 2002 Jul-Aug;4(4):304-11 [12082546.001]
  • [Cites] Genes Dev. 2002 May 1;16(9):1060-5 [12000789.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):183-90 [11958372.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):145-53 [11958368.001]
  • [Cites] J Neurooncol. 2001 Dec;55(3):149-58 [11859969.001]
  • [Cites] Int J Cancer. 2001 Oct 15;94(2):218-21 [11668501.001]
  • [Cites] Virchows Arch. 2001 Aug;439(2):176-84 [11561758.001]
  • [Cites] Int J Oncol. 2001 Sep;19(3):609-12 [11494043.001]
  • [Cites] Cancer Genet Cytogenet. 2001 Aug;129(1):88-91 [11520574.001]
  • [Cites] Clin Cancer Res. 2001 Aug;7(8):2269-76 [11489801.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):661-9 [11485924.001]
  • [Cites] Growth Horm IGF Res. 2001 Apr;11(2):84-91 [11472074.001]
  • [Cites] Clin Cancer Res. 1999 Feb;5(2):237-41 [10037170.001]
  • [Cites] Cancer. 1999 Jan 15;85(2):485-91 [10023719.001]
  • [Cites] Neurosurgery. 1998 Oct;43(4):890-8; discussion 898-9 [9766317.001]
  • [Cites] Humangenetik. 1972;14(2):167-9 [4112733.001]
  • [Cites] Hereditas. 1972;71(1):163-8 [4142025.001]
  • (PMID = 18978964.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2459329
  • [Keywords] NOTNLM ; Aggressive / atypical / biology / meningioma / treatment
  •  go-up   go-down


57. Hamdi R, De Korvin H, Speeg-Schatz C, Szwarcberg J: [Combined hamartoma of the retina and retinal pigment epithelium. Four case studies]. J Fr Ophtalmol; 2006 Mar;29(3):e6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Hamartome combiné de l'épithélium pigmentaire et de la rétine. A propos de 4 cas.
  • This study aimed to demonstrate the advantages of early diagnosis and regular monitoring.
  • OBSERVATIONS: We report a series of four children followed between 2001 and 2004 with combined hamartoma of the retina and retinal pigment epithelium, with age of diagnosis ranging from 3 months to 8 years.
  • DISCUSSION: Combined hamartoma of the retina and retinal pigment epithelium is probably a congenital tumor whose pathogenesis has not yet been elucidated.
  • The diagnosis is clinical and the patient can be thoroughly examined by retinal angiography and optical coherence tomography (OCT).
  • In this disorder, it is important to eliminate retinoblastoma and malignant melanoma of the choroid, showing the advantage of radiological exploration.
  • This tumor can progress in spite of its benign character.
  • [MeSH-major] Hamartoma. Pigment Epithelium of Eye. Retinal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16557165.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


58. Bodack MI: Ptosis and cranial nerve IV palsy reveal juvenile myasthenia gravis. Optometry; 2009 Jul;80(7):342-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In both cases, these conditions can be benign and require no further workup.
  • If a patient presents with multiple neurologic signs, a sudden onset eye turn, or ptosis, the patient must undergo a workup to rule out a pathologic etiology, specifically a brain tumor.
  • If the results of the neuroimaging are normal, and the findings are variable, myasthenia gravis should be considered, and additional testing should be ordered to assist in the diagnosis.
  • Diagnosis of myasthenia gravis was made based on clinical presentation and response to ice pack testing.
  • CONCLUSIONS: Although rare, myasthenia should be considered a diagnosis in children who present with variable ptosis or strabismus.
  • [MeSH-major] Blepharoptosis / etiology. Myasthenia Gravis / complications. Myasthenia Gravis / diagnosis. Strabismus / etiology. Trochlear Nerve Diseases / etiology
  • [MeSH-minor] Child, Preschool. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Neurology. Optometry. Referral and Consultation

  • Genetic Alliance. consumer health - Myasthenia gravis.
  • Genetic Alliance. consumer health - Ptosis.
  • MedlinePlus Health Information. consumer health - Myasthenia Gravis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Optometry. 2009 Sep;80(9):466
  • (PMID = 19545846.001).
  • [ISSN] 1558-1527
  • [Journal-full-title] Optometry (St. Louis, Mo.)
  • [ISO-abbreviation] Optometry
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Zhang CF, Dong FT, Chen YX, Du H, Han BL: [Clinical manifestation and follow-up of melanocytoma of the optic disc]. Zhonghua Yan Ke Za Zhi; 2009 Apr;45(4):296-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All cases were unilateral involved, 5 cases were right eye, 5 cases were left eye.
  • The distribution of the visual acuity was follows: light perception in 2 eyes, 20/200 in one eye, 20/20 or above in 7 eyes.
  • The tumor mass at the optic disc with extensive serous detachment of retina was detected on B-scan in one eye.
  • The benign melanocytoma was diagnosed by vitreous fine needle biopsy for this eye.
  • In other case, the tumor was found to be enlarged, visual field defect deteriorated, pigment granules appeared in the vitreous adjacent to the tumor during on year follow-up period.
  • On the patient request, enucleation was performed to rule out the malignancy of the tumor.
  • Pathologic study showed that the tumor cells were active, but benign state.
  • The tumor size and visual acuity in other eight eyes remained stable in the follow-up period with one to 18 years (mean 3.5 years).
  • On FFA and ICGA, bilateral choroidal nevi were found in one eye.
  • CONCLUSIONS: Melanocytoma of the optic disc is a benign tumor that rarely causes visual impairment.
  • However, visual acuity may be impaired due to enlargement of the tumor or necrosis in tumor.
  • [MeSH-major] Melanoma / diagnosis. Optic Disk / pathology. Optic Nerve Neoplasms / diagnosis
  • [MeSH-minor] Adult. Choroid Neoplasms / diagnosis. Female. Follow-Up Studies. Humans. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19575959.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


60. Alkatan HM, Al-Arfaj KM, Maktabi A: Conjunctival nevi: Clinical and histopathologic features in a Saudi population. Ann Saudi Med; 2010 Jul-Aug;30(4):306-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND OBJECTIVE: Conjunctival nevi are benign lesions with wide variation in clinical and histopathological features.
  • The differentiation between benign nevi and other pigmented lesions is essential.
  • The aim of our study was to identify the distribution of the histopathologic types of conjunctival nevi among the Saudi population and to provide the basic knowledge needed for proper clinical diagnosis.
  • PATIENTS AND METHODS: This retrospective study of surgically excised benign conjunctival nevi was conducted at a tertiary care eye hospital from 1995 to 2006.
  • CONCLUSIONS: The distribution of the histopathologic types of this tumor in our population matches the pattern in other areas of the world with the compound nevus being the commonest lesion.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Nevus, Pigmented / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Ophthalmol. 2002 Jan;86(1):28-30 [11801498.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1850-6 [12036989.001]
  • [Cites] Arch Ophthalmol. 2004 Feb;122(2):167-75 [14769591.001]
  • [Cites] Ophthalmol Clin North Am. 2005 Mar;18(1):15-24, vii [15763188.001]
  • [Cites] Ophthalmology. 1989 Apr;96(4):436-61 [2657539.001]
  • [Cites] Ophthalmology. 1989 Jul;96(7):986-93 [2771364.001]
  • [Cites] Acta Ophthalmol Scand. 1996 Aug;74(4):334-7 [8883545.001]
  • [Cites] Ophthalmology. 1988 Aug;95(8):1053-7 [3231443.001]
  • (PMID = 20622349.001).
  • [ISSN] 0975-4466
  • [Journal-full-title] Annals of Saudi medicine
  • [ISO-abbreviation] Ann Saudi Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  • [Other-IDs] NLM/ PMC2931783
  •  go-up   go-down


61. Boonman ZF, van Mierlo GJ, Fransen MF, de Keizer RJ, Jager MJ, Melief CJ, Toes RE: Maintenance of immune tolerance depends on normal tissue homeostasis. J Immunol; 2005 Oct 1;175(7):4247-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we analyzed whether tolerance toward an intraocular tumor expressing a highly immunogenic CTL epitope is maintained, broken, or reverted into immunity in the event the anatomical integrity of the eye is lost.
  • Inoculation of tumor cells into the anterior chamber of the eye of naive B6 mice leads to progressive intraocular tumor growth, an abortive form of CTL activation in the tumor-draining submandibular lymph node, and systemic tolerance as evidenced by the inability of these mice to reject an otherwise benign tumor cell inoculum.
  • Loss of anatomical integrity of the eye as a consequence of phthisis resulted in loss of systemic tolerance and the emergence of effective antitumor immunity against an otherwise lethal tumor challenge.
  • Phthisis was accompanied by dendritic cell maturation and preceded the induction of systemic tumor-specific CTL immunity.
  • Our data show that normal tissue homeostasis and anatomical integrity is required for the maintenance of ocular tolerance and prevention of CTL-mediated immunity.
  • [MeSH-major] Eye Neoplasms / immunology. Homeostasis / immunology. Immune Tolerance / physiology
  • [MeSH-minor] Animals. Anterior Chamber / immunology. Antigen Presentation / immunology. Antigen-Presenting Cells / metabolism. Antigens, CD11c / metabolism. Antigens, Neoplasm / immunology. Cell Line, Transformed. Cell Line, Tumor. Cross-Priming / immunology. Mice. Mice, Inbred C57BL. Mice, Knockout. Mice, Transgenic. T-Lymphocytes, Cytotoxic / immunology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16177064.001).
  • [ISSN] 0022-1767
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD11c; 0 / Antigens, Neoplasm
  •  go-up   go-down


62. Fine HF, Ferrara DC, Ho IV, Takahashi B, Yannuzzi LA: Bilateral choroidal osteomas with polypoidal choroidal vasculopathy. Retin Cases Brief Rep; 2008;2(1):15-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: A choroidal osteoma is a benign osseous tumor typically arising in the juxtapapillary or peripapillary area.
  • To our knowledge, this variant form of vasogenesis has not previously been described in association with this tumor.
  • Subretinal hemorrhage in the left eye from polypoidal neovascularization in the macula was successfully treated with photodynamic therapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25389606.001).
  • [ISSN] 1935-1089
  • [Journal-full-title] Retinal cases & brief reports
  • [ISO-abbreviation] Retin Cases Brief Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Zhou L, Chen X, Huang W, Li K, Zhang X, Wang W: [Surgical management of minor salivary gland tumors]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Nov;21(21):963-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: Retrospective analysis of 54 cases with minor salivary gland tumor operated in our hospital from 1997 to 2004.
  • Among the remaining 38 patients, 2 patients with nasal cavity adenoid cystic carcinoma died of tumor recurrence 2 and 3 years after the surgery respectively, one patient with laryngeal myoepithelial carcinoma died of tumor recurrence 3 years after the surgery and one patient with paranasal sinus mucoepidermoid carcinoma died of recurrence 17 months after the surgery.
  • Two patients with paranasal sinus adenoid cystic carcinoma recurred after the primary surgery and were survived without tumor after salvage surgery.
  • The other patients survived with no tumor recurrence.
  • The treatment policy for benign tumors is simple tumor excision, while that for malignant tumors is surgery combined with pre- or post-operative radiation therapy.
  • Complete surgical resection of tumor masses and tumor free margin is essential for successful treatment of malignant minor salivary gland tumors.
  • [MeSH-major] Salivary Gland Neoplasms / surgery. Salivary Glands, Minor / surgery

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18309648.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


64. Tang DR, Shi XF, Sun FY, Zhao H, Jin YJ: [Clinical features and therapy of benign lymphoepithelial lesion]. Zhonghua Yan Ke Za Zhi; 2009 May;45(5):441-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical features and therapy of benign lymphoepithelial lesion].
  • OBJECTIVE: To report the clinical features of benign lymphoepithelial lesion and to further characterize recommendations for its therapy strategy.
  • Retrospective analyze the clinical characteristics, imaging features, pathological manifestation and the treatment effect from the clinical materials of 9 cases of patients with benign lymphoepithelial lesion presenting to Tianjin Eye Hospital from Jan 2006 to Dec 2007.
  • RESULTS: The 9 cases, in which 7 cases were female, 7 cases had lesions on both eyes, demonstrated unpainful swelling of the lacrimal glands and in different degree of salivary glands or had history of tumor resection of salivary glands.
  • Three patients were operated to excise the lacrimal gland masses due to imperfect treatment effect of medication or in order to make definite diagnosis.
  • The postoperative pathological results supported the diagnosis of benign lymphoepithelial lesion.
  • CONCLUSIONS: A clinical condition with swelling of either or both lacrimal gland and of any salivary gland, and accompanied with systemic relative diseases should be considered benign lymphoepithelial lesion.
  • Imaging examinations are helpful to definite diagnosis.
  • The definite diagnosis should be made through pathological examinations.
  • [MeSH-major] Mikulicz' Disease / diagnosis. Mikulicz' Disease / drug therapy

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19576068.001).
  • [ISSN] 0412-4081
  • [Journal-full-title] [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
  • [ISO-abbreviation] Zhonghua Yan Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Glucocorticoids
  •  go-up   go-down


65. McKenna M, Brodsky L: Extraesophageal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol; 2005 May;69(5):597-605
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Recurrent respiratory papillomatosis (RRP) is a benign infectious disease which is caused by the human papilloma virus (HPV).
  • The clinical course of the papillomatosis and the diagnosis and treatment of reflux are compared over time.
  • Prompt diagnosis and effective treatment of EERD should be considered in all patients with difficult to control RRP or with clinical presentation or endoscopic signs of EERD.
  • [MeSH-major] Gastroesophageal Reflux / complications. Gastroesophageal Reflux / diagnosis. Laryngeal Neoplasms / complications. Neoplasm Recurrence, Local / complications. Papilloma / complications
  • [MeSH-minor] Airway Obstruction / etiology. Airway Obstruction / therapy. Child. Child, Preschool. Humans. Male. Papillomaviridae. Papillomavirus Infections / complications. Papillomavirus Infections / therapy. Severity of Illness Index. Tumor Virus Infections / complications. Tumor Virus Infections / therapy

  • MedlinePlus Health Information. consumer health - GERD.
  • MedlinePlus Health Information. consumer health - Reflux in Children.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Pediatr Otorhinolaryngol. 2006 Apr;70(4):757-8; author reply 759 [16242786.001]
  • (PMID = 15850681.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


66. Han Z, Lin GJ, Chi FL, Wang SY, Huang JM, Liu HJ, Zhang LR: The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma. ORL J Otorhinolaryngol Relat Spec; 2008;70(6):352-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Thirty-three cases of benign and malignant laryngeal tumors were included.
  • RESULTS: The expression of ECM1 (p = 0.004) and HA (p = 0.036) was significantly different between benign and malignant tumors.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoma, Squamous Cell / secondary. Extracellular Matrix Proteins / metabolism. Laryngeal Neoplasms / pathology. Neovascularization, Pathologic / pathology
  • [MeSH-minor] Adult. Aged. Biopsy, Needle. Cohort Studies. Female. Humans. Immunohistochemistry. Lymph Nodes / pathology. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Metastasis. Neoplasm Staging. Probability. Prognosis. Risk Assessment. Sampling Studies. Sensitivity and Specificity. Statistics, Nonparametric. Survival Analysis

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel.
  • (PMID = 18984970.001).
  • [ISSN] 1423-0275
  • [Journal-full-title] ORL; journal for oto-rhino-laryngology and its related specialties
  • [ISO-abbreviation] ORL J. Otorhinolaryngol. Relat. Spec.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / ECM1 protein, human; 0 / Extracellular Matrix Proteins
  •  go-up   go-down


67. Kashkouli MB, Khalatbari MR, Yahyavi T, Borghei Razavi H, Shayanfar N, Parvaresh MM: Primary endo-orbital osteoid osteoma. Orbit; 2008;27(3):211-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteiod osteoma is a small, benign, osteoblastic tumor, which usually affects the long bone of the lower extremities and vertebrae.
  • A 22-year-old man presented with eyelid edema, proptosis and pain in the left eye 1 year after the beginning of the symptoms.
  • [MeSH-major] Orbital Neoplasms / pathology. Orbital Neoplasms / surgery. Osteoma, Osteoid / pathology. Osteoma, Osteoid / surgery
  • [MeSH-minor] Adult. Biopsy, Needle. Exophthalmos / diagnosis. Exophthalmos / etiology. Follow-Up Studies. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Neoplasm Staging. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18569832.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


68. Arora R, Monga S, Mehta DK, Raina UK, Gogi A, Gupta SD: Malignant fibrous histiocytoma of the conjunctiva. Clin Exp Ophthalmol; 2006 Apr;34(3):275-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They can occur in any part of the body including the orbital tissues.
  • Eleven of these were classified as benign, and the rest were malignant fibrous histiocytomas.
  • Benign fibrous histiocytomas have been reported in the orbit, eyelid, episclera and conjunctiva.
  • Malignant fibrous histiocytoma has been well described in the orbit, but rarely as a primary conjunctival tumour.
  • The rarity of the tumour makes its diagnosis and management a challenge.
  • Herein, the clinicopathological features of a case of malignant fibrous histiocytoma are presented and its management with wide excision and cryotherapy followed by ocular reconstruction with amniotic membrane transplant is discussed.
  • [MeSH-major] Conjunctival Neoplasms / pathology. Histiocytoma, Malignant Fibrous / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Humans. Male. Middle Aged. Neoplasm Proteins / metabolism

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16671910.001).
  • [ISSN] 1442-6404
  • [Journal-full-title] Clinical & experimental ophthalmology
  • [ISO-abbreviation] Clin. Experiment. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


69. Igaki T, Pagliarini RA, Xu T: Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol; 2006 Jun 6;16(11):1139-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila.
  • However, the underlying mechanisms of how cell polarity disruption contributes to tumor progression are unknown.
  • Here, using a Drosophila genetic model for Ras-induced tumor progression, we show a molecular link between loss of cell polarity and tumor malignancy.
  • Mutation of different apicobasal polarity genes activates c-Jun N-terminal kinase (JNK) signaling and downregulates the E-cadherin/beta-catenin adhesion complex, both of which are necessary and sufficient to cause oncogenic Ras(V12)-induced benign tumors in the developing eye to exhibit metastatic behavior.
  • Furthermore, activated JNK and Ras signaling cooperate in promoting tumor growth cell autonomously, as JNK signaling switches its proapoptotic role to a progrowth effect in the presence of oncogenic Ras.
  • Our finding that such context-dependent alterations promote both tumor growth and metastatic behavior suggests that metastasis-promoting mutations may be selected for based primarily on their growth-promoting capabilities.
  • [MeSH-major] Drosophila / enzymology. Drosophila Proteins / metabolism. JNK Mitogen-Activated Protein Kinases / metabolism. Neoplasms, Experimental / enzymology
  • [MeSH-minor] Animals. Apoptosis / genetics. Cadherins / metabolism. Cell Polarity / genetics. Disease Models, Animal. Enzyme Activation. Eye / pathology. Neoplasm Metastasis. Proto-Oncogene Proteins p21(ras) / metabolism. Signal Transduction. beta Catenin / metabolism

  • COS Scholar Universe. author profiles.
  • FlyBase. FlyBase .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16753569.001).
  • [ISSN] 0960-9822
  • [Journal-full-title] Current biology : CB
  • [ISO-abbreviation] Curr. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cadherins; 0 / Drosophila Proteins; 0 / beta Catenin; EC 2.7.11.24 / JNK Mitogen-Activated Protein Kinases; EC 3.6.5.2 / Proto-Oncogene Proteins p21(ras)
  •  go-up   go-down


70. Boulos PR, Knoepp SM, Rubin PA: Green bone. Arch Ophthalmol; 2007 Mar;125(3):380-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To describe the unusual finding of yellow-green-colored bone during routine orbital surgery, to detail its investigation, and to demonstrate its benign nature.
  • RESULTS: Yellow-green bone was encountered in 3 patients during orbital tumor excision or orbital fracture repair procedures.
  • In all cases, absence of neoplasia was demonstrated histologically.
  • [MeSH-minor] Adult. Color. Humans. Male. Microscopy, Fluorescence. Microscopy, Ultraviolet. Middle Aged. Orbital Fractures / surgery. Orbital Neoplasms / radiography. Orbital Neoplasms / surgery. Spectrophotometry, Ultraviolet. Tomography, X-Ray Computed

  • Hazardous Substances Data Bank. TETRACYCLINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17353410.001).
  • [ISSN] 0003-9950
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protein Synthesis Inhibitors; F8VB5M810T / Tetracycline
  •  go-up   go-down


71. Fine JL, Kagemann L, Wollstein G, Ishikawa H, Schuman JS: Direct scanning of pathology specimens using spectral domain optical coherence tomography: a pilot study. Ophthalmic Surg Lasers Imaging; 2010 Nov-Dec;41 Suppl:S58-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Subtle textures that were suggestive of benign breast lobules and ovarian tumor features were also visible.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010, SLACK Incorporated.
  • [Cites] J Biomed Opt. 2002 Jul;7(3):457-63 [12175297.001]
  • [Cites] Arch Ophthalmol. 2003 May;121(5):695-706 [12742848.001]
  • [Cites] Hum Pathol. 2009 Aug;40(8):1057-69 [19552937.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 Aug;66(8):750-9 [17882019.001]
  • [Cites] Hum Pathol. 2008 Apr;39(4):564-72 [18234276.001]
  • [Cites] Ophthalmology. 2005 Oct;112(10):1734-46 [16140383.001]
  • (PMID = 21117602.001).
  • [ISSN] 1938-2375
  • [Journal-full-title] Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye
  • [ISO-abbreviation] Ophthalmic Surg Lasers Imaging
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / P30 EY008098; United States / NEI NIH HHS / EY / R01 EY013178; United States / NEI NIH HHS / EY / P30-EY08098; United States / NEI NIH HHS / EY / R01-EY13178
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS307169; NLM/ PMC3147151
  •  go-up   go-down


72. Kinoshita S, Kakizaki H, Iwaki M, Hara K: [Two cases of dermolipoma]. Nippon Ganka Gakkai Zasshi; 2007 Dec;111(12):965-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Dermolipoma is an uncommon benign tumor, congenitally occurring on the conjunctiva, and may be present at other sites.
  • The appearance of dermolipoma closely resembles orbital fat prolapse and limbal dermoid, and therefore it is necessary to take this into account in diagnosis.
  • CASE REPORT: The first case was a 52-year-old female patient referred for the treatment of an orbital fat prolapse in her right eye.
  • Another case, an 8-year-old female patient, was referred for the treatment of a bulbar conjunctival tumor in her left eye.
  • In both cases, dermolipoma was suspected because the tumor did not show in the limbus and it did not change in size even when the eyeball was pressed.
  • CONCLUSIONS: If the special features of dermolipoma are understood, it is easy to distinguish this tumor from other disorders.
  • [MeSH-minor] Child. Conjunctival Neoplasms / congenital. Conjunctival Neoplasms / surgery. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18186219.001).
  • [ISSN] 0029-0203
  • [Journal-full-title] Nippon Ganka Gakkai zasshi
  • [ISO-abbreviation] Nippon Ganka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


73. Romer M, Bode B, Schuknecht B, Schmid S, Holzmann D: Solitary fibrous tumor of the orbit--two cases and a review of the literature. Eur Arch Otorhinolaryngol; 2005 Feb;262(2):81-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor of the orbit--two cases and a review of the literature.
  • Solitary fibrous tumors of the orbit (SFT) are mesenchymal lesions that can develop either as malignant or benign neoplasias.
  • We describe the histological features leading to the diagnosis in two females and review the current literature.
  • Diagnosis of SFT only can be performed by histological examination, since clinical signs and radiological features are not specific enough.
  • Even a malignant or benign course cannot be predicted, since clinical and radiological features do not correlate with histological signs of malignancy and vice versa.
  • [MeSH-major] Neoplasms, Fibrous Tissue / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ophthal Plast Reconstr Surg. 2003 Jan;19(1):68-74 [12544795.001]
  • [Cites] Eye (Lond). 2001 Feb;15(Pt 1):102-4 [11318269.001]
  • [Cites] Am J Surg Pathol. 1989 Aug;13(8):640-58 [2665534.001]
  • [Cites] Hum Pathol. 1999 Dec;30(12):1464-73 [10667425.001]
  • [Cites] Arch Pathol Lab Med. 2000 May;124(5):756-8 [10782163.001]
  • [Cites] Am J Ophthalmol. 1996 Apr;121(4):447-9 [8604743.001]
  • [Cites] Am J Surg Pathol. 1991 Feb;15(2):126-30 [1989459.001]
  • [Cites] Surg Neurol. 2001 Oct;56(4):242-6 [11738672.001]
  • [Cites] Am J Surg Pathol. 1994 Mar;18(3):281-7 [8116796.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1241-5 [11846919.001]
  • [Cites] Dtsch Med Wochenschr. 2001 Jan 5;126(1-2):12-5 [11200659.001]
  • [Cites] Eye (Lond). 2001 Feb;15(Pt 1):124-6 [11318283.001]
  • [Cites] Am J Surg Pathol. 1995 Nov;19(11):1286-93 [7573691.001]
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):185-94 [10026737.001]
  • [Cites] Mod Pathol. 1999 May;12 (5):463-71 [10349983.001]
  • [Cites] Ophthal Plast Reconstr Surg. 1998 Jan;14(1):57-61 [9513245.001]
  • [Cites] Am J Surg Pathol. 1994 Oct;18(10):992-8 [7522416.001]
  • [Cites] Hum Pathol. 2000 Sep;31(9):1108-15 [11014579.001]
  • [Cites] Neurosurgery. 1996 May;38(5):1040-3 [8727832.001]
  • [Cites] Jpn J Ophthalmol. 2001 Jul-Aug;45(4):412-9 [11485776.001]
  • [Cites] Cancer. 1981 Jun 1;47(11):2678-89 [7260861.001]
  • [Cites] Orbit. 2002 Mar;21(1):49-54 [12029582.001]
  • [Cites] Diagn Cytopathol. 2001 Sep;25(3):172-6 [11536441.001]
  • [Cites] Eye (Lond). 1996;10 ( Pt 3):396-9 [8796170.001]
  • [Cites] Am J Surg Pathol. 1991 Sep;15(9):842-8 [1719831.001]
  • [Cites] Histopathology. 1986 Aug;10(8):867-75 [2428726.001]
  • [Cites] Brain Pathol. 2003 Jan;13(1):111-2, 117 [12580551.001]
  • [Cites] J Craniofac Surg. 2002 Sep;13(5):641-4 [12218791.001]
  • [Cites] Mod Pathol. 1997 May;10(5):443-50 [9160308.001]
  • [Cites] Pathol Int. 1995 Dec;45(12):952-7 [8808301.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 May;17 (3):207-14 [11388388.001]
  • [Cites] Ophthalmology. 1996 Oct;103(10):1613-8 [8874434.001]
  • [Cites] Histopathology. 1996 Feb;28(2):188-91 [8834532.001]
  • [Cites] Int Ophthalmol. 1998;22(5):265-8 [10826541.001]
  • [Cites] Can J Ophthalmol. 1997 Dec;32(7):432-5 [9435973.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1996 Oct;122(10):1130, 1132 [8859128.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2001 Sep;17(5):369-73 [11642494.001]
  • [Cites] Am J Ophthalmol. 2000 Sep;130(3):373-6 [11020428.001]
  • [Cites] Am J Surg Pathol. 2000 Jul;24(7):971-9 [10895819.001]
  • [Cites] Neuroradiology. 1999 Jan;41(1):52-4 [9987770.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):570-4 [12136289.001]
  • (PMID = 15316820.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


74. Uhlirova M, Jasper H, Bohmann D: Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model. Proc Natl Acad Sci U S A; 2005 Sep 13;102(37):13123-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model.
  • The role of c-Jun N-terminal kinase (JNK) signaling in cancer is enigmatic, and both tumor-promoting and tumor-suppressing functions have been ascribed to JNK pathway components.
  • We have used the Drosophila eye to investigate the function of the JNK pathway in three different tumor models of increasing malignancy.
  • Benign lesions caused by loss of the neoplastic tumor suppressor gene scribble can efficiently be eliminated by JNK-induced apoptosis.
  • In such a scenario, the eye reverts to a wild-type phenotype, indicating that the JNK pathway prevents tumor formation.
  • The situation changes in the case of aggressive tissue overgrowth, which can be induced by oncogenic activation of the Ras/Raf pathway in the eye, or in malignant invasive tumors resulting when Raf activation is combined with loss of scribble.
  • The growth of these more aggressive tumor types is significantly, yet incompletely, suppressed by JNK-mediated apoptosis.


75. Cordero Coma M, Yilmaz T, Foster CS: Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid. Acta Ophthalmol Scand; 2007 Nov;85(7):753-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumour necrosis factor-alpha in conjunctivae affected by ocular cicatricial pemphigoid.
  • PURPOSE: The presence of tumour necrosis factor-alpha (TNF-alpha) in conjunctivae affected by ocular cicatricial pemphigoid (OCP) was investigated.
  • [MeSH-major] Conjunctiva / metabolism. Conjunctivitis, Allergic / metabolism. Pemphigoid, Benign Mucous Membrane / metabolism. Tumor Necrosis Factor-alpha / metabolism


76. Robinson JW, Brownstein S, Jordan DR, Hodge WG: Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature. Surv Ophthalmol; 2006 Sep-Oct;51(5):513-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature.
  • The woman was undergoing mitomycin C injections for ocular cicatricial pemphigoid, diagnosed in the same eye 2 years prior to identification of the neoplasm.
  • The tumor invaded the cornea, sclera, lacrimal gland, regional small nerves, and lymphatics, but did not show intraocular involvement.
  • [MeSH-major] Carcinoma, Mucoepidermoid / pathology. Conjunctival Neoplasms / pathology. Conjunctivitis / complications. Pemphigoid, Benign Mucous Membrane / complications
  • [MeSH-minor] Basement Membrane / pathology. Biopsy. Drug Therapy, Combination. Female. Fluorometholone / therapeutic use. Humans. Middle Aged. Mitomycin / therapeutic use. Neoplasm Invasiveness. Ofloxacin / therapeutic use


77. Godeiro KD, Frota AC, Antecka E, Odashiro AN, Maloney S, Fernandes B, Burnier MN Jr: Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane. J Carcinog; 2006;5:21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prostate-specific membrane antigen (PSMA) is a type II membrane glycoprotein expressed in benign and malignant prostatic tissues, in some non-prostatic tissues, and in the endothelium of tumor-associated neovasculature of non-prostatic neoplasm.
  • Some studies have suggested that the expression of PSMA is restricted to endothelium from tumor-associated neovasculature and might be stimulated by some tumor-secreted angiogenic factors.
  • However, no previous study demonstrating PSMA expression in non-related tumor neovasculature, such as CNVM, has been performed to date.
  • CONCLUSION: The absence of PSMA expression in non-tumoral neovasculature supports the theory, previously suggested, that endothelial cell PSMA expression may be stimulated by one or more tumor-secreted angiogenic factors.
  • Angiogenesis is very important in neoplasia and the endothelial expression of PSMA in tumor-associated neovasculature may represent a target for antineovasculature-based therapy.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1999 Jul 1;59(13):3192-8 [10397265.001]
  • [Cites] Clin Cancer Res. 1996 Sep;2(9):1445-51 [9816319.001]
  • [Cites] Urology. 2001 Jun;57(6):1179-83 [11377343.001]
  • [Cites] Br J Ophthalmol. 2001 Oct;85(10):1153-7 [11567955.001]
  • [Cites] Mol Vis. 2002 Apr 21;8:119-26 [11979237.001]
  • [Cites] Surv Ophthalmol. 2003 May-Jun;48(3):257-93 [12745003.001]
  • [Cites] Am J Ophthalmol. 2004 Mar;137(3):496-503 [15013874.001]
  • [Cites] Eye (Lond). 2006 Mar;20(3):341-6 [15905873.001]
  • [Cites] Ophthalmology. 1992 Jun;99(6):933-43 [1630784.001]
  • [Cites] Cancer Res. 1990 Oct 1;50(19):6423-9 [1698122.001]
  • [Cites] Anticancer Res. 1987 Sep-Oct;7(5B):927-35 [2449118.001]
  • [Cites] Ophthalmology. 1984 Dec;91(12):1603-8 [6084226.001]
  • [Cites] Cancer Res. 1993 Jan 15;53(2):227-30 [8417812.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):749-53 [8570628.001]
  • [Cites] Arch Ophthalmol. 1997 Feb;115(2):242-50 [9046260.001]
  • [Cites] Ophthalmology. 1995 Oct;102(10):1450-60 [9097791.001]
  • [Cites] Cancer Res. 1997 Sep 1;57(17):3629-34 [9288760.001]
  • [Cites] Clin Cancer Res. 1997 Jan;3(1):81-5 [9815541.001]
  • [Cites] Clin Cancer Res. 1999 Oct;5(10):2674-81 [10537328.001]
  • (PMID = 16911781.001).
  • [ISSN] 1477-3163
  • [Journal-full-title] Journal of carcinogenesis
  • [ISO-abbreviation] J Carcinog
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1560378
  •  go-up   go-down


78. Looi A, Kazim M, Cortes M, Rootman J: Orbital reconstruction after eyelid- and conjunctiva-sparing orbital exenteration. Ophthal Plast Reconstr Surg; 2006 Jan-Feb;22(1):1-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Case selection is emphasized, as this technique is mainly reserved for histopathologically benign orbital lesions that exhibit local aggressive behavior and for malignant lesions only if there is no eyelid, lacrimal gland, or orbital fissure involvement nor significant conjunctival or deep extension of an intraocular tumor.
  • [MeSH-minor] Adult. Aged. Child. Eye Neoplasms / surgery. Female. Follow-Up Studies. Humans. Male. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16418657.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Lavaju P, Arya SK, Sinha A, Pandey S, Adhikari S, Shrestha BG, Chetan S, Agarwal TL: Pattern of ocular tumors in the eastern region of Nepal. Nepal J Ophthalmol; 2009 Jan-Jun;1(1):9-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pattern of ocular tumors in the eastern region of Nepal.
  • BACKGROUND: ocular tumors are commonly encountered in ophthalmic practice.
  • OBJECTIVE: to study the clinical pattern of ocular tumors in the eastern region of Nepal.
  • MATERIALS AND METHODS: the hospital records of patients with ocular tumors treated at B P Koirala Institute of Health Sciences in the eastern region of Nepal over a period of 5 years (April 2003 - March 2008) were studied retrospectively.
  • RESULTS: of 115 consecutive patients with ocular tumors, 40 (34.75%) were below the age of 21 years, 41 (35.65%) were in the age group of 21-50 years and 34 (29.56%) of age above 50 years.
  • There were 48 (41.73%) and 67 (58.26%) patients with benign and malignant tumors respectively.
  • The common benign tumors were conjunctival papilloma, dermoid cysts, nevus, cystic lesions and hemangioma.
  • Retinoblastoma was the most common ocular malignant tumor in the pediatric age group (88.8%).
  • CONCLUSION: conjunctival papilloma, dermoid cysts, nevus, cystic lesions and hemangioma are common benign ocular tumors, whereas basal cell carcinoma and retinoblastoma are the commonest ocular malignancies in adults and children respectively.
  • [MeSH-major] Eye Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21141015.001).
  • [ISSN] 2072-6805
  • [Journal-full-title] Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
  • [ISO-abbreviation] Nepal J Ophthalmol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


80. He MX, Song B, Jiang H, Hu XG, Zhang YJ, Zheng JM: Complete resection of isolated pancreatic metastatic melanoma: a case report and review of the literature. World J Gastroenterol; 2010 Sep 28;16(36):4621-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of a 39-year-old Chinese male with a solitary pancreatic tumor which was considered a cystic benign lesion for years.
  • Pathology and immunohistochemistry showed that the tumor in pancreatic tail was a metastasis from a malignant melanoma of the eyeball.
  • The tumor was completely resected with combined distal pancreatectomy and splenectomy.
  • [MeSH-major] Eye Neoplasms / pathology. Melanoma. Pancreatic Neoplasms / secondary. Pancreatic Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Male. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg Oncol. 2006 May;13(5):712-20 [16538410.001]
  • [Cites] Am J Gastroenterol. 1996 Nov;91(11):2414-7 [8931428.001]
  • [Cites] Przegl Lek. 2007;64(4-5):372-3 [17724919.001]
  • [Cites] Ann Surg Oncol. 2008 Nov;15(11):3199-206 [18784960.001]
  • [Cites] J Surg Res. 2009 Oct;156(2):189-98 [19375718.001]
  • [Cites] Ann Plast Surg. 2010 Feb;64(2):135 [20098090.001]
  • [Cites] Pancreas. 2010 Mar;39(2):135-43 [19820422.001]
  • [Cites] Ann Surg. 2010 Apr;251(4):775-6; author reply 777-8 [20224355.001]
  • [Cites] Ann Surg. 2010 Apr;251(4):776-7; author reply 777-8 [20224357.001]
  • [Cites] Surgery. 2010 Jul;148(1):151-4 [19744448.001]
  • [Cites] Pancreas. 2010 Jul;39(5):577-80 [20173671.001]
  • [Cites] Eur J Surg Oncol. 1998 Apr;24(2):127-30 [9591028.001]
  • [Cites] Ann Surg Oncol. 2001 Sep;8(8):658-62 [11569781.001]
  • [Cites] Pathol Int. 2001 Sep;51(9):686-90 [11696171.001]
  • [Cites] Pancreas. 2003 Aug;27(2):201-3 [12883272.001]
  • [Cites] Cancer. 2004 Jan 1;100(1):122-9 [14692032.001]
  • [Cites] Ann Surg. 1990 Aug;212(2):173-7 [2375648.001]
  • [Cites] Rev Esp Enferm Dig. 1992 Jul;82(1):61-2 [1520555.001]
  • [Cites] Pathologica. 1992 Jul-Aug;84(1092):531-7 [1491895.001]
  • [Cites] Pancreas. 1993 Mar;8(2):276-8 [8460104.001]
  • [Cites] Langenbecks Arch Surg. 2007 Sep;392(5):539-42 [17242893.001]
  • (PMID = 20857537.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2945498
  •  go-up   go-down


81. Andrei S, Zemba M, Bratulescu M, Dobrescu N, Cucu B, Popescu A, Cuzino D, Curea M: [Cataract surgery in an eye with intraocular tumor]. Oftalmologia; 2005;49(4):41-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cataract surgery in an eye with intraocular tumor].
  • [Transliterated title] Consecintele efectuării operatiei de cataractă pe un ochi cu tumoră intraoculară--caz clinic.
  • This case present the consequences of performing the cataract surgery on an eye with intraocular tumor, pointing the importance of a detailed and complete examination, even for the benign and easy to diagnostic diseases.
  • [MeSH-major] Cataract Extraction. Choroid Neoplasms / diagnosis. Eye / pathology. Melanoma / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Eye Enucleation. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Eye Care.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16524125.001).
  • [ISSN] 1220-0875
  • [Journal-full-title] Oftalmologia (Bucharest, Romania : 1990)
  • [ISO-abbreviation] Oftalmologia
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


82. Benatiya Andaloussi I, Touiza E, Bhallil S, Oudidi A, Bouayed MA, Daoudi K, El Alami MN, Tahri H: Orbital osteoma: three case reports. Bull Soc Belge Ophtalmol; 2006;(300):73-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Osteoma is the most frequent benign tumor of paranasal sinuses.
  • The management consisted in a surgical excision of the whole tumor by external approach, associated with a dacryocystorhinostomy.
  • 2nd observation: Miss K.A. is a 16 years-old caucasian female who came to consultation for a swelling of the medial angle of the left eye.
  • The tumor was removed through an external ethmoidectomy.
  • The computed tomography is of a great contribution, not only for diagnosis but also for the choice of the surgical approach.
  • This surgery may induce ocular or neurochirurgical complications.
  • [MeSH-major] Orbital Neoplasms / diagnosis. Osteoma / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16903514.001).
  • [ISSN] 0081-0746
  • [Journal-full-title] Bulletin de la Société belge d'ophtalmologie
  • [ISO-abbreviation] Bull Soc Belge Ophtalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


83. Nichols KE, Walther S, Chao E, Shields C, Ganguly A: Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol; 2009 Sep;20(5):351-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE OF REVIEW: Retinoblastoma is a pediatric eye tumor that serves as a paradigm for understanding the genetic basis of cancer.
  • RECENT FINDINGS: Current data demonstrate that retinomas, benign retinal tumors found in some retinoblastoma patients, exhibit bi-allelic mutations in RB1, the retinoblastoma gene, and lack of expression of the retinoblastoma protein.
  • [MeSH-major] Retinal Neoplasms / genetics. Retinoblastoma / genetics

  • Genetic Alliance. consumer health - Retinoblastoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19587599.001).
  • [ISSN] 1531-7021
  • [Journal-full-title] Current opinion in ophthalmology
  • [ISO-abbreviation] Curr Opin Ophthalmol
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 1R01CA118580-01A2; United States / NCI NIH HHS / CA / R21 CA123196-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Retinoblastoma Protein
  • [Number-of-references] 46
  •  go-up   go-down


84. Tsuchiya T, Nakahama K, Asakawa Y, Maemura T, Tanaka M, Takeda S, Morita M, Morita I: The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Gynecol Endocrinol; 2009 Feb;25(2):104-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Microvessel density (MVD) was evaluated by the total microvessel length in high-power field of tumor tissue preparations.
  • RESULTS: MVD correlated with tumor malignancy.
  • The VEGF expression levels in some malignant tumors (VEGF-L) were as low as that in benign tumors.
  • The PEDF expression levels in VEGF-L malignant tumors were significantly lower than those in benign tumors.
  • On the other hand, the PEDF expression levels in VEGF-H malignant tumor tissues were not significantly different from those in benign tumors.
  • CONCLUSION: The reduction in PEDF expression levels may be, in part, responsible for tumor malignancy in VEGF-L ovarian tumors.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / physiopathology. Eye Proteins / genetics. Nerve Growth Factors / genetics. Ovarian Neoplasms / pathology. Ovarian Neoplasms / physiopathology. Serpins / genetics. Vascular Endothelial Growth Factor A / genetics
  • [MeSH-minor] Adenocarcinoma, Clear Cell / blood supply. Adenocarcinoma, Clear Cell / pathology. Adenocarcinoma, Clear Cell / physiopathology. Biomarkers, Tumor / metabolism. Blotting, Western. Carcinoma, Endometrioid / blood supply. Carcinoma, Endometrioid / pathology. Carcinoma, Endometrioid / physiopathology. Female. Gene Expression Regulation, Neoplastic. Humans. Microcirculation / physiology. Neoplasms / blood supply. Neoplasms / pathology. Neoplasms / physiopathology. Neovascularization, Pathologic / metabolism. Neovascularization, Pathologic / pathology. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19253105.001).
  • [ISSN] 1473-0766
  • [Journal-full-title] Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • [ISO-abbreviation] Gynecol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Eye Proteins; 0 / Nerve Growth Factors; 0 / Serpins; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A; 0 / pigment epithelium-derived factor
  •  go-up   go-down


85. Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM: Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol; 2006 Nov;169(5):1767-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
  • Platelet-derived growth factor (PDGF) stimulates tumor growth and progression by affecting tumor and stromal cells.
  • In the HaCaT skin carcinogenesis model, transfection of immortal nontumorigenic and PDGF-receptor-negative HaCaT keratinocytes with PDGF-B induced formation of benign tumors.
  • In vivo, persistent PDGF-B expression induced enhanced tumor cell proliferation but only transiently stimulated stromal cell proliferation and angiogenesis.
  • The PDGF-induced, persistently increased expression of the hepatocyte growth factor by fibroblasts in vitro and in vivo was most probably responsible for enhanced epithelial cell proliferation and benign tumor formation.
  • Thus, by paracrine stimulation of the stroma, PDGF-BB induced epithelial hyperproliferation, thereby promoting tumorigenicity, whereas the time-limited activation of the stroma followed by stromal maturation provides a possible explanation for the benign tumor phenotype.
  • [MeSH-major] Epithelial Cells / drug effects. Epithelial Cells / pathology. Growth Substances / pharmacology. Neoplasms / pathology. Phenotype. Platelet-Derived Growth Factor / pharmacology. Stromal Cells / drug effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Development. 1999 Jun;126(14):3047-55 [10375497.001]
  • [Cites] Cancer Res. 1987 Jul 1;47(13):3425-9 [3034415.001]
  • [Cites] Cancer Res. 1999 Oct 1;59(19):5002-11 [10519415.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Aug;84(16):5763-7 [3039506.001]
  • [Cites] J Cell Biol. 1988 Mar;106(3):761-71 [2450098.001]
  • [Cites] Science. 1988 Jun 10;240(4858):1529-31 [2836952.001]
  • [Cites] EMBO J. 1988 Dec 1;7(12):3727-35 [2463166.001]
  • [Cites] Cancer Res. 1990 May 1;50(9):2840-7 [2183932.001]
  • [Cites] Cancer Res. 1990 Oct 1;50(19):6130-8 [1698118.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):2021-5 [1848018.001]
  • [Cites] Lab Invest. 1991 Mar;64(3):321-9 [1848332.001]
  • [Cites] Am J Pathol. 1992 Mar;140(3):639-48 [1372158.001]
  • [Cites] Lab Invest. 1992 Oct;67(4):529-34 [1434531.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):393-7 [8380638.001]
  • [Cites] J Clin Invest. 1993 May;91(5):2065-75 [8486774.001]
  • [Cites] Histochem J. 1993 Apr;25(4):251-66 [7684033.001]
  • [Cites] Am J Pathol. 1997 Aug;151(2):479-92 [9250160.001]
  • [Cites] Exp Cell Res. 1997 Aug 1;234(2):434-41 [9260914.001]
  • [Cites] Methods Mol Biol. 1997;75:305-11 [9276280.001]
  • [Cites] Nat Med. 1997 Nov;3(11):1222-7 [9359696.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1050-5 [9448283.001]
  • [Cites] Development. 1998 May;125(9):1591-8 [9521897.001]
  • [Cites] Histochem Cell Biol. 1998 Apr;109(4):349-57 [9562384.001]
  • [Cites] Exp Cell Res. 1998 Apr 10;240(1):1-6 [9570915.001]
  • [Cites] Circ Res. 1999 Feb 19;84(3):298-305 [10024303.001]
  • [Cites] Nat Rev Cancer. 2004 Nov;4(11):839-49 [15516957.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1294-305 [15735015.001]
  • [Cites] Exp Cell Res. 2005 Jul 15;307(2):292-304 [15950618.001]
  • [Cites] Exp Eye Res. 2006 Jan;82(1):74-80 [16198337.001]
  • [Cites] Blood. 2006 Mar 1;107(5):1896-902 [16322476.001]
  • [Cites] J Clin Invest. 1994 Jan;93(1):131-9 [7506710.001]
  • [Cites] J Cell Biol. 1994 May;125(4):917-28 [7514607.001]
  • [Cites] Int J Cancer. 1995 Jan 17;60(2):168-73 [7829210.001]
  • [Cites] Int J Cancer. 1997 Mar 28;71(1):42-8 [9096664.001]
  • [Cites] Int J Cancer. 2000 Feb 1;85(3):398-406 [10652433.001]
  • [Cites] Oncogene. 2000 Sep 7;19(38):4337-45 [10980609.001]
  • [Cites] FASEB J. 2001 Feb;15(2):447-57 [11156960.001]
  • [Cites] Semin Cancer Biol. 2001 Apr;11(2):97-104 [11322829.001]
  • [Cites] Bioessays. 2001 Jun;23(6):494-507 [11385629.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12072-7 [11593017.001]
  • [Cites] Lab Invest. 2001 Dec;81(12):1709-16 [11742041.001]
  • [Cites] J Biol Chem. 2002 Apr 5;277(14):12456-62 [11799124.001]
  • [Cites] Am J Pathol. 2002 Jul;161(1):135-43 [12107098.001]
  • [Cites] Microvasc Res. 2002 Nov;64(3):372-83 [12453432.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):486-97 [12492491.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):537-46 [12492495.001]
  • [Cites] Am J Pathol. 2003 Feb;162(2):533-46 [12547711.001]
  • [Cites] Lab Invest. 2003 Feb;83(2):163-73 [12594232.001]
  • [Cites] Nat Med. 2003 Jun;9(6):685-93 [12778167.001]
  • [Cites] Acta Biochim Pol. 2003;50(3):647-58 [14515146.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71 [15051869.001]
  • [Cites] J Cell Biol. 1982 Feb;92(2):584-8 [7061598.001]
  • [Cites] J Clin Invest. 1982 Apr;69(4):1046-9 [7076844.001]
  • [Cites] Cell. 1986 Jul 18;46(2):155-69 [3013421.001]
  • [Cites] N Engl J Med. 1986 Dec 25;315(26):1650-9 [3537791.001]
  • [Cites] Physiol Rev. 1999 Oct;79(4):1283-316 [10508235.001]
  • (PMID = 17071599.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Endostatins; 0 / Growth Substances; 0 / Platelet-Derived Growth Factor; 0 / Proto-Oncogene Proteins c-sis; 0 / RNA, Messenger; 0 / Vascular Endothelial Growth Factor A; 0 / platelet-derived growth factor BB; 67256-21-7 / Hepatocyte Growth Factor; EC 2.7.10.1 / Receptors, Platelet-Derived Growth Factor
  • [Other-IDs] NLM/ PMC1780216
  •  go-up   go-down


86. Burduk PK, Seredyka-Burduk M, Olejarz E: [Giant tumor of the orbit--a case of hidradenoma]. Otolaryngol Pol; 2007;61(6):1017-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant tumor of the orbit--a case of hidradenoma].
  • The most common symptoms are ophthalmology dysfunction as: exophthalmus, eye movement dysfunction and visual loss.
  • More often a benign lesions is found than malignant.
  • We present a case of 62 years old man with large expansion of benign tumor of the orbit with exophthalmus, eye movement disability and complete blindness.
  • Histopathology described a very rare tumor of the orbit-hidradenoma.
  • [MeSH-major] Adenoma, Sweat Gland / diagnosis. Orbital Neoplasms / diagnosis. Sweat Gland Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18546956.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


87. Singh AD, Kaiser PK, Sears JE: Choroidal hemangioma. Ophthalmol Clin North Am; 2005 Mar;18(1):151-61, ix
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Choroidal hemangioma is an uncommon benign vascular tumor of the choroid that can be circumscribed or diffuse.
  • Diffuse choroidal hemangiomas are usually evident at birth and generally occur as a part of neuro-oculo-cutaneous hemangiomatosis (Sturge-Weber syndrome).
  • [MeSH-major] Choroid Neoplasms / pathology. Hemangioma / pathology
  • [MeSH-minor] Choroid / pathology. Choroid / ultrasonography. Combined Modality Therapy. Diagnosis, Differential. Fluorescein Angiography. Fundus Oculi. Humans. Magnetic Resonance Imaging. Prognosis. Sturge-Weber Syndrome / diagnosis. Sturge-Weber Syndrome / therapy

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15763200.001).
  • [ISSN] 0896-1549
  • [Journal-full-title] Ophthalmology clinics of North America
  • [ISO-abbreviation] Ophthalmol Clin North Am
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 55
  •  go-up   go-down


88. Song JJ, Finger PT, Kurli M, Wisnicki HJ, Iacob CE: Giant secondary conjunctival inclusion cysts: a late complication of strabismus surgery. Ophthalmology; 2006 Jun;113(6):1049.e1-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The patient's ocular history, ophthalmic examinations, and imaging (ultrasound/ultrasound biomicroscopy and/or computed tomography) were recorded.
  • Histopathologic evaluations were consistent with benign inclusion cysts of the conjunctiva.
  • Tumor size, cystic nature, and involvement of underlying structures can be determined by ultrasonography and radiographic imaging.

  • MedlinePlus Health Information. consumer health - After Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16631253.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


89. Vijayalakshmi P, Jethani J, Kim U: Congenital unilateral ocular fibrosis syndrome secondary to benign congenital tumor. Indian J Ophthalmol; 2006 Jun;54(2):123-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital unilateral ocular fibrosis syndrome secondary to benign congenital tumor.
  • We report a case of this rare syndrome associated with an adjacent sinus tumor.
  • [MeSH-major] Oculomotor Muscles / pathology. Orbital Neoplasms / complications
  • [MeSH-minor] Diagnosis, Differential. Female. Fibrosis / congenital. Fibrosis / etiology. Fibrosis / pathology. Humans. Infant. Magnetic Resonance Imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16770032.001).
  • [ISSN] 0301-4738
  • [Journal-full-title] Indian journal of ophthalmology
  • [ISO-abbreviation] Indian J Ophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


90. Perlmann E, da Silva EG, Guedes PM, Barros PS: Co-existing squamous cell carcinoma and hemangioma on the ocular surface of a cat. Vet Ophthalmol; 2010 Jan;13(1):63-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Co-existing squamous cell carcinoma and hemangioma on the ocular surface of a cat.
  • A 14-year-old spayed female domestic short-haired cat was presented for evaluation of a mass in the right eye.
  • Ophthalmic examination revealed a blind right eye and presence of two distinct masses: a pink and a red-to-brown mass, the latter occupying most of the cornea and part of the conjunctiva.
  • Exenteration was performed under general anesthesia, and the ocular tissues were processed routinely for histopathology.
  • Upon microscopic examination, a malignant epithelial neoplasm and a benign vascular neoplasm were present in the cornea.
  • Upon immunohistochemistry, the epithelial tumor was positive for cytokeratin and negative for vimentin and the endothelial tumor was negative for cytokeratin and positive for vimentin.
  • A diagnosis of squamous cell carcinoma (SCC) and hemangioma was made.
  • To the authors' knowledge, this is the first report of concomitant SCC and hemangioma affecting the ocular surface in a cat.
  • [MeSH-major] Carcinoma, Squamous Cell / veterinary. Cat Diseases / pathology. Eye Neoplasms / veterinary. Hemangioma / veterinary. Neoplasms, Multiple Primary / veterinary


91. Tamura K, Aoyagi M, Wakimoto H, Tamaki M, Yamamoto K, Yamamoto M, Ohno K: Malignant transformation eight years after removal of a benign epidermoid cyst: a case report. J Neurooncol; 2006 Aug;79(1):67-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant transformation eight years after removal of a benign epidermoid cyst: a case report.
  • Malignant transformation of benign epidermoid cysts is rare and their prognosis remains poor.
  • A 56-year-old woman presented with left facial hypoesthesia and photophobia in the left eye.
  • She had undergone removal of a benign epidermoid cyst in the cerebellopontine angle 8 years previously.
  • She underwent removal again and the histopathologic diagnosis was squamous cell carcinoma.
  • The tumor shrank rapidly for 2 months after radiosurgery, but recurred 9 months later.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Cell Transformation, Neoplastic / pathology. Cerebellar Neoplasms / pathology. Cerebellopontine Angle / pathology. Epidermal Cyst / pathology
  • [MeSH-minor] Female. Gadolinium. Humans. Image Enhancement. Magnetic Resonance Imaging. Middle Aged. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Radiosurgery

  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1995 Jul-Aug;19(4):628-30 [7622698.001]
  • [Cites] No Shinkei Geka. 1987 Aug;15(8):851-8 [3323934.001]
  • [Cites] J Neurosurg. 2002 Nov;97(5):1237-43 [12450053.001]
  • [Cites] AJNR Am J Neuroradiol. 1991 Nov-Dec;12(6):1182-4 [1763747.001]
  • [Cites] J Neurosurg. 1983 Sep;59(3):538-41 [6886769.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1984;402(4):459-64 [6202051.001]
  • [Cites] J Neurosurg. 1965 Oct;23(4):384-93 [5853888.001]
  • [Cites] Neurol Med Chir (Tokyo). 1999 Jan;39(1):49-54 [10093462.001]
  • [Cites] Cancer. 1973 Mar;31(3):713-8 [4693599.001]
  • [Cites] Acta Neurochir (Wien). 1987;85(1-2):34-9 [3604769.001]
  • [Cites] Neurol Med Chir (Tokyo). 2003 Jun;43(6):275-80; discussion 281 [12870545.001]
  • [Cites] J Clin Neurosci. 2001 Nov;8(6):572-4 [11683611.001]
  • [Cites] Cancer. 2005 May 15;103(10):2143-53 [15816051.001]
  • [Cites] J Neurosurg. 1979 Jun;50(6):830-3 [312314.001]
  • [Cites] AJNR Am J Neuroradiol. 1989 Mar-Apr;10(2):351-6 [2494855.001]
  • [Cites] J Neurosurg. 1964 Dec;21:1051-8 [14279825.001]
  • [Cites] Neurosurgery. 1989 Apr;24(4):574-8 [2651960.001]
  • [Cites] No Shinkei Geka. 1990 Nov;18(11):1041-5 [2247198.001]
  • [Cites] J Neurosurg. 1981 Oct;55(4):654-6 [7277016.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1965 Jun;28:276-81 [14345685.001]
  • [Cites] J Neurosurg. 1987 Apr;66(4):618-20 [3559730.001]
  • [Cites] Neurol Med Chir (Tokyo). 1989 Jul;29(7):600-5 [2477760.001]
  • [Cites] N Engl J Med. 1977 Feb 3;296(5):271-6 [299778.001]
  • [Cites] J Comput Assist Tomogr. 1981 Jun;5(3):433-5 [6972395.001]
  • [Cites] Br J Neurosurg. 1993;7(5):565-9 [8267896.001]
  • [Cites] Br J Neurosurg. 1991;5(3):303-5 [1892574.001]
  • [Cites] Neurosurgery. 1995 Aug;37(2):329-32 [7477788.001]
  • [Cites] No Shinkei Geka. 1995 Oct;23(10):905-9 [7477700.001]
  • [Cites] Curr Opin Oncol. 1997 May;9(3):262-6 [9229149.001]
  • (PMID = 16583265.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] AU0V1LM3JT / Gadolinium
  •  go-up   go-down


92. Ohnishi Y, Saika S, Yamanaka O, Okada Y, Shirai K, Miyamoto T, Nishikawa I, Tanaka T, Miyazaki K: [Investigation of mechanism of cell proliferation regulation and its clinical application]. Nippon Ganka Gakkai Zasshi; 2005 Dec;109(12):865-83; discussion 884
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cell proliferation and related cellular behavior in ocular neoplastic disease and in the healing process in ocular surgery or post-injury management, as well as new treatment strategy were investigated.
  • Cell proliferation-related signals were found to be activated to a greater extent in malignant ocular tumors than in benign tumor cells regardless of the similarity of simple histological findings.
  • Suppression of cell proliferation-related signals can be a new treatment for ocular neoplastic diseases.
  • [MeSH-minor] Animals. Eye Neoplasms / pathology. Eye Neoplasms / therapy. Gene Expression Regulation, Developmental. Genetic Therapy. Hedgehog Proteins. Humans. Ocular Physiological Phenomena. Trans-Activators / physiology. Wound Healing / genetics. Wound Healing / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16408488.001).
  • [ISSN] 0029-0203
  • [Journal-full-title] Nippon Ganka Gakkai zasshi
  • [ISO-abbreviation] Nippon Ganka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Hedgehog Proteins; 0 / Smad Proteins; 0 / Trans-Activators; 0 / Transcription Factor AP-1; 0 / Transforming Growth Factor beta
  • [Number-of-references] 77
  •  go-up   go-down


93. Bianciotto C, Shields CL, Lally SE, Freire J, Shields JA: CyberKnife radiosurgery for the treatment of intraocular and periocular lymphoma. Arch Ophthalmol; 2010 Dec;128(12):1561-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lymphoma type was classified as extranodal marginal zone B-cell lymphoma in 7 eyes (50%), diffuse large B-cell lymphoma in 3 eyes (21%), follicular lymphoma in 2 eyes (14%), and benign reactive lymphoid hyperplasia in 2 eyes (14%).
  • Complete tumor resolution without local recurrence over a mean follow-up of 23 months was documented in all cases.
  • Radiation-associated adverse effects included mild dry eye in 2 patients and cataract in 1 patient with conjunctival lymphoma.
  • There was no radiation retinopathy or papillopathy, and visual acuity was preserved or improved in 13 eyes and decreased in 1 eye due to the presence of cataract.
  • [MeSH-major] Eye Neoplasms / surgery. Lymphoma, Non-Hodgkin / surgery. Pseudolymphoma / surgery. Radiosurgery

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21149780.001).
  • [ISSN] 1538-3601
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Lessell S, Kim JW, Hatton MP, Stemmer-Rachamimov A, Thiagalingham S, Rubin PA: Clinical without histopathological manifestations of inflammation in a patient with primary intraorbital optic nerve sheath meningioma. J Neuroophthalmol; 2007 Jun;27(2):104-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 28-year-old man with a biopsy-proven benign intraorbital optic nerve sheath meningioma developed recurrent clinical manifestations of ipsilateral retrobulbar inflammation 9 years after undergoing postoperative radiation therapy.
  • Debulking of the tumor 11 years after the original surgery again revealed no pathologic signs of inflammation.
  • Whether growth of tumor, surgery, radiation, or edema triggered the inflammatory manifestations is unclear.
  • [MeSH-major] Inflammation / complications. Meningeal Neoplasms / complications. Meningioma / complications. Optic Nerve Neoplasms / complications

  • Genetic Alliance. consumer health - Meningioma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17548993.001).
  • [ISSN] 1070-8022
  • [Journal-full-title] Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • [ISO-abbreviation] J Neuroophthalmol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Lally DR, Shields JF, Shields CL, Marr BP, Shields JA: Pigmented free-floating vitreous cyst in a child. J Pediatr Ophthalmol Strabismus; 2008 Jan-Feb;45(1):47-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An 8-year-old asymptomatic boy was referred for a pigmented fundus lesion in his left eye that was suspected to be a possible choroidal melanoma.
  • Visual acuity was 20/20 in each eye.
  • Ocular examination in the upright position revealed a pigmented lesion measuring 4 mm in diameter and 3 mm in thickness located inferior to the fovea.
  • Observation of the benign vitreous cyst was advised.
  • A free-floating pigmented cyst can resemble a pigmented intraocular tumor, particularly if it is immediately preretinal.
  • [MeSH-major] Cysts / diagnosis. Eye Diseases / diagnosis. Pigment Epithelium of Eye / pathology. Vitreous Body / pathology

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18286964.001).
  • [ISSN] 0191-3913
  • [Journal-full-title] Journal of pediatric ophthalmology and strabismus
  • [ISO-abbreviation] J Pediatr Ophthalmol Strabismus
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


96. Frei-Jones M, McKinstry RC, Perry A, Leonard JR, Park TS, Rubin JB: Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma. J Neurosurg Pediatr; 2008 Aug;2(2):125-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infantile or capillary hemangioma is the most common vascular tumor of childhood.
  • Although the lesions are considered benign, 10% of affected children develop life-threatening complications (mortality rate 20-80% in this subgroup).
  • [MeSH-major] Angiogenesis Inhibitors / therapeutic use. Brain Neoplasms / congenital. Brain Neoplasms / drug therapy. Hemangioma, Capillary / congenital. Hemangioma, Capillary / drug therapy. Thalidomide / therapeutic use

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. THALIDOMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plast Reconstr Surg. 1982 Mar;69(3):412-22 [7063565.001]
  • [Cites] AJNR Am J Neuroradiol. 2007 Jan;28(1):25-9 [17213418.001]
  • [Cites] N Engl J Med. 1992 May 28;326(22):1456-63 [1489383.001]
  • [Cites] Semin Vasc Surg. 1993 Dec;6(4):204-18 [8305975.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5 [7513432.001]
  • [Cites] N Engl J Med. 1995 Dec 28;333(26):1757-63 [7491141.001]
  • [Cites] Exp Eye Res. 1997 Jun;64(6):971-8 [9301478.001]
  • [Cites] J Pediatr. 1998 Mar;132(3 Pt 1):527-30 [9544915.001]
  • [Cites] N Engl J Med. 1962 Dec 6;267:1184-92 contd [13934699.001]
  • [Cites] N Engl J Med. 1962 Dec 13;267:1238-44 concl [13934700.001]
  • [Cites] Eur J Pediatr Surg. 2005 Feb;15(1):11-6 [15795821.001]
  • [Cites] Med Hypotheses. 2005;64(6):1093-6 [15823691.001]
  • [Cites] Plast Reconstr Surg. 2005 Jul;116(1):200-4 [15988268.001]
  • [Cites] Pathology. 2005 Apr;37(2):149-51 [16028843.001]
  • [Cites] J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81 [16282886.001]
  • [Cites] Pediatr Dermatol. 2006 Mar-Apr;23(2):169-74 [16650230.001]
  • [Cites] Eye (Lond). 2006 Oct;20(10):1228-37 [17019424.001]
  • [Cites] Br J Ophthalmol. 2006 Nov;90(11):1344-9 [16854824.001]
  • [Cites] Pediatrics. 2002 Feb;109(2):E37 [11826247.001]
  • [Cites] J Pediatr Surg. 2004 Mar;39(3):400-4 [15017560.001]
  • [Cites] Childs Nerv Syst. 2006 Nov;22(11):1427-31 [16804715.001]
  • [Cites] J Pediatr Surg. 1983 Dec;18(6):894-900 [6663421.001]
  • (PMID = 18671617.001).
  • [ISSN] 1933-0707
  • [Journal-full-title] Journal of neurosurgery. Pediatrics
  • [ISO-abbreviation] J Neurosurg Pediatr
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / K30 RR022251; United States / NCRR NIH HHS / RR / TL1 RR024995; United States / NCRR NIH HHS / RR / UL1 RR024992; United States / NCRR NIH HHS / RR / UL1 RR024992; United States / NCRR NIH HHS / RR / UL1 RR024992-01; United States / NCATS NIH HHS / TR / UL1 TR000448
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 4Z8R6ORS6L / Thalidomide
  • [Other-IDs] NLM/ NIHMS101679; NLM/ PMC2737696
  •  go-up   go-down


97. Kloek CE, Bilyk JR, Pribitkin EA, Rubin PA: Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex. Ophthalmology; 2006 Jul;113(7):1214-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex.
  • PURPOSE: Tumors located in the intraconal portion of the orbital apex, especially those inferior to the optic nerve, can be difficult to access surgically, carrying a significant risk of ocular morbidity.
  • The purpose of this study was to investigate outcomes in 5 patients with benign-appearing but symptomatic tumors located in the intraconal portion of the orbital apex in which orbital decompression was performed as an alternative management strategy to resection.
  • PARTICIPANTS: Five patients were diagnosed with a compressive optic neuropathy secondary to a benign-appearing tumor at the orbital apex.
  • None of the patients had the tumor biopsied or resected.
  • CONCLUSIONS: Orbital decompression is a therapeutic option for patients with compressive optic neuropathies from benign orbital apex tumors, offering potential improvement in optic nerve function while sparing morbidity from attempts at surgical resection.
  • [MeSH-major] Decompression, Surgical. Nerve Compression Syndromes / surgery. Optic Nerve Diseases / surgery. Orbit / surgery. Orbital Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Optic Nerve Disorders.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ophthalmology. 2007 Mar;114(3):619-20; author reply 620-1 [17324707.001]
  • (PMID = 16815404.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Al-Rashaed S, Abboud EB, Nowilaty SR: Characteristics of optic disc melanocytomas presenting with visual dysfunction. Middle East Afr J Ophthalmol; 2010 Jul;17(3):242-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE AND DESIGN: A retrospective review study was designed to describe five cases of optic disc melanocytomas with tumor-related visual impairment.
  • PARTICIPANTS: Five patients with optic disc melanocytoma presented with visual complaints to a tertiary eye hospital in Saudi Arabia.
  • MATERIALS AND METHODS: Demographic and clinical data were analyzed, including the results of ocular examination, lesion laterality, best-corrected Snellen visual acuity, pupillary reflex, visual field testing, color fundus photography, fundus fluorescein angiography, and ophthalmic ultrasound.
  • Case 1 had macular star edema with mild tumor enlargement, Case 2 had optic atrophy, Case 3 had juxtapapillary choroidal neovascular membrane with macular involvement, Case 4 had optic disc swelling with an enlarged blind spot, and Case 5 had a large altitudinal visual field defect.
  • CONCLUSION: Although melanocytomas of the optic disc tend to have a benign behavior with slow evolution and stable vision, they may adversely affect visual function through a variety of mechanisms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20844679.001).
  • [ISSN] 0975-1599
  • [Journal-full-title] Middle East African journal of ophthalmology
  • [ISO-abbreviation] Middle East Afr J Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2934715
  • [Keywords] NOTNLM ; Melanocytoma / Optic Disc / Visual Function
  •  go-up   go-down


99. Tam ES, Chen EC, Nijhawan N, Harvey JT, Howarth D, Oestreicher JH: Solitary fibrous tumor of the orbit: a case series. Orbit; 2008;27(6):426-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor of the orbit: a case series.
  • PURPOSE: Solitary fibrous tumor (SFT) occurs rarely in the orbit.
  • We present four such cases, representing one of the largest case series reported to date of this rare orbital tumor.
  • METHOD: The four patients ranged from ages 20 to 50, all of whom presented with lid swelling or bulging in the involved eye.
  • All four patients underwent CT scan to confirm the diagnosis of an orbital mass, which was then excised.
  • One of these cases demonstrated residual tumor on follow-up CT scan, which remained unchanged at one-year follow-up.
  • No evidence of residual tumor was found in the other three cases, despite one having malignant pathology.
  • CONCLUSION: SFT is a rare and generally benign tumor of the orbit.
  • Immunohistochemical testing with CD34 is necessary to confirm the diagnosis.
  • Although en bloc tumor resection is the definitive treatment, residual tumor may remain stable for some time.
  • [MeSH-major] Fibroma / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD34 / analysis. Biomarkers, Tumor / analysis. Female. Humans. Male. Middle Aged. Neoplasm Proteins / analysis. Tomography, X-Ray Computed. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19085297.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; 0 / Vimentin
  •  go-up   go-down


100. Kodama S, Okamoto T, Suzuki M: Sinonasal schwannoma with new bone formation expressing bone morphogenic protein. Int J Otolaryngol; 2010;2010:154948
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schwannoma is a benign tumor that arises from the sheath of myelinated nerve fibers and may occur in any part of the body.
  • The tumor was successfully treated by endoscopic sinus surgery, and the patient showed no evidence of recurrence 24 months postoperatively.
  • Immunohistochemically, the tumor expressed bone morphogenic protein 4, indicating a possible role of this protein in the new bone formation in schwannomas.

  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 1999 Dec;(369):296-301 [10611885.001]
  • [Cites] Acta Neurochir (Wien). 2002 Apr;144(4):395-9 [12021889.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Oct 26;362(3):550-3 [17719560.001]
  • [Cites] Am J Rhinol. 2007 Sep-Oct;21(5):607-10 [17999798.001]
  • [Cites] Genes Dev. 1996 Jul 1;10(13):1580-94 [8682290.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2000;257(7):402-5 [11052256.001]
  • [Cites] Eye (Lond). 2004 Feb;18(2):218; discussion 218-9 [14762430.001]
  • [Cites] Otolaryngol Head Neck Surg. 2006 Feb;134(2):343-4 [16455392.001]
  • [Cites] Am J Rhinol. 2006 Jan-Feb;20(1):64-71 [16539297.001]
  • [Cites] J Laryngol Otol. 2008 Jun;122(6):598-602 [17705894.001]
  • [Cites] Spine J. 2009 May;9(5):e19-23 [19138570.001]
  • [Cites] Otolaryngol Head Neck Surg. 2001 Jul;125(1):96-7 [11458222.001]
  • [Cites] Rhinology. 2001 Sep;39(3):169-72 [11721510.001]
  • [Cites] Rhinology. 1988 Sep;26(3):217-9 [3143145.001]
  • [Cites] Cancer. 1994 Aug 1;74(3):842-7 [8039112.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Jan 15;25(2):268-72 [10685494.001]
  • (PMID = 21197441.001).
  • [ISSN] 1687-921X
  • [Journal-full-title] International journal of otolaryngology
  • [ISO-abbreviation] Int J Otolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3010644
  •  go-up   go-down






Advertisement